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ABSTRACT 
Poisoning is a major health problem in northern Vietnam. The aims of these studies 
were to improve prevention, differential diagnosis and treatment of this threat to the 
public. 
A hospital-based retrospective study of poisoning emergencies admitted to the first 
Poison Control Center (PCC) in Vietnam during the years 1999 and 2003 (Paper I) 
revealed that a vast majority of the poisoning emergencies occurred at home. 
Pesticides, hypnotic pharmaceuticals and heroin were among the most commonly 
involved toxic agents and entailed an increased risk of a fatal outcome. The 
frequently recorded severe toxic symptoms, including coma, respiratory failure, 
hypotension and seizures, indicate a need for more specialized clinical poisoning 
units with intensive care facilities in Vietnam.  
A cross-sectional community-based study from a rural part of Vietnam (Paper IV) 
pointed out that the availability and accessibility of pesticides constitute the main risk 
factor for poisoning among ordinary people in Vietnam. A second important source of 
toxins in the rural area of Vietnam is its poisonous flora and fauna. Other common risk 
factors for poisoning were the availability and inadequate storage of hazardous 
household products and self-medication of pharmaceuticals purchased at retail 
pharmacies without professional consultation. 
A retrospective study of 60 consecutive patients envenomed by Bungarus multicinctus 
treated at the intensive care unit (ICU) of the PCC during the 4-year period 2000-2003 
(Paper II) demonstrated that bites by this particular krait species commonly occur in 
rural areas and during night-time. The first symptoms developed within a wide time-
range of 0.5 to 24 hours. The dilatation of the pupils was often maximal and extremely 
persistent in some cases. A majority of the patients developed generalized muscle 
paralysis and 87%  of the study population needed mechanical ventilation. The new and 
surprising finding of a high rate of significant hyponatremia makes frequent laboratory 
monitoring and sometimes prompt sodium replacement imperative, and the severe 
clinical features recorded indicate an urgent need for a specific antivenom. 
A controlled clinical trial of a novel antivenom against B. multicinctus during a three-
year period (2004-2006) at the ICU of the PCC (Paper III) clearly demonstrated its 
favourable efficacy and acceptable safety. The prospective study also confirmed the 
new finding in paper II of a high risk for development of significant hyponatremia after 
snakebite by this particular species.  
In conclusion, the epidemiological hospital- and community-based studies provided 
fundamental information needed for improved poisoning prevention in Vietnam. The 
retrospective study identified important clinical information regarding envenoming by 
B. multicinctus. The new finding of a high rate of clinically significant hyponatremia 
makes repeated monitoring of electrolytes and in some cases prompt sodium 
replacement imperative. The controlled clinical trial demonstrated the efficacy and 
safety of the novel specific antivenom against B. multicinctus and thereby set up a 
principal treatment routine for  patients envenomed by B. multicinctus.     
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1 INTRODUCTION 
1.1 EPIDEMIOLOGY OF ACUTE POISONING IN DEVELOPING 
COUNTRIES 
Poisoning is a significant threat to public health globally and constitutes a common 
cause of medical emergencies. Defined as drug overdose, food poisoning, or 
symptomatic exposure to an environmental toxin, poisoning is an extensive health care 
problem. According to WHO data, an estimated 350,000 people died worldwide in 
2002 from unintentional poisoning. In the year 2000, poisoning was the ninth most 
common cause of death in young adults worldwide and there were more than three 
million cases of poisoning, with a mortality rate of approximately 8% [1]. It has been 
estimated that over 90% of such fatalities occur in developing countries [1].  
The panorama of frequently occurring toxins and exposure hazards differs considerably 
from country to country. Thus, epidemiological studies with toxicological surveillance 
data for each country are necessary to determine the countries’ specific problems and 
risks, so that preventive measures can be taken. However, toxico-epidemiological data 
from developing countries are sparse [1]. 
Most epidemiological studies of poisoning in developing countries have been based on 
either hospital treated cases or on data from poison information centers. These studies 
have shown that pesticides are the most important toxins world-wide due to wide 
spread use and high mortality rates. Poisoning by pharmaceuticals, household products 
and natural toxins are also common and important causes of morbidity and mortality in 
developing countries [2, 3]. 
Vietnam is a developing country with approximately 86 million inhabitants. Its 
population is relatively young, 39% consisting of children and adolescents, while 17% 
are elderly [4]. In general Vietnam is an agricultural country and farmers account for 
nearly 75% of its population, forming a large market for biocides and other toxic 
chemicals. As a result of ready availability of poisons and the lack of an effective 
control strategy, poisoning has become a major health problem throughout the country. 
However, reliable data on poisoning patterns in Vietnam are sparse and incomplete, 
and to our knowledge no study on clinical toxicological issues from this country has 
been previously published in any international medical journal. Moreover, potentially 
hazardous factors for poisonings have not been thoroughly studied. 
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Pesticides 
Agrochemical pesticides are a major public health problem throughout the developing 
world [5]. Many farming households have stocks of pesticides readily available for 
impulsive acts. Storage facilities and knowledge of the toxicity of the agents are 
frequently poor [6, 7].  
Insecticides 
Organophosphorus (OP) pesticides were responsible for a majority of the deaths in 
most series of self-poisoning cases in the developing countries, particularly those from 
rural areas [8-10].  
Carbamates are less toxic than OP pesticides. However, a series of seven deaths due to 
furathiocarb self-poisoning was reported from Korea in the year 1999 [11].  
Poisoning with the organochlorines endosulfan and endrin has recently become an 
important cause of seizures in parts of South Asia [12, 13]. They cause a status 
epilepticus that is usually unresponsive to standard treatment, requiring general 
anaesthesia. These pesticides are rapidly metabolized by the body and therefore, if the 
patient can be supported through the status epilepticus, prognosis is good with few 
residual complications [14]. 
As for other pesticides, the compounds abamectin and ivermectin (both avermectins) 
are used for the control of parasite infections in crops and cattle. Out of 19 patients 
reported to a Taiwanese poison control centre between 1993 - 1997, seven showed 
marked toxicity with coma, respiratory failure and hypotension. One patient died. 
Fourteen cases (six severe) were categorized as self-poisoning [15].  
Pyrethrins are less toxic than most other insecticides. A few cases of self-poisoning 
have been reported from India [16].  
Herbicides 
The dipyridyl pesticides paraquat and diquat are highly toxic. Paraquat has been 
reported to be a problem in many parts of the world, including Korea [17, 18], Malaysia 
[19], Singapore [20], Sri Lanka [21], Taiwan [22] and Thailand [23].  
Glyphosate is another type of herbicide. Two case series from Taiwan have described 
181 patients with such poisoning. The most common symptoms reported was 
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gastrointestinal tract irritation. Severe cases showed cardiogenic shock, respiratory 
insufficiency, renal failure, and metabolic acidosis. Eighteen patients died [24, 25].  
Rodenticides 
Aluminium phosphide is toxic after ingestion because contact with water in the 
stomach liberates phosphine gas. It has become one of the commonest means of 
self‐poisoning in northern India [26]. A study from Chandigarh, India, showed that it is 
also a common means of self‐harm amongst adolescents, with a mortality rate of 59% 
[27].  
Long-acting ‘superwarfarin’ compounds such as brodifacoum cause long-term 
coagulopathies and have been used for self-poisoning world-wide. This type of 
rodenticide poisoning has, for example, been reported from Hong Kong [28].  
Pharmaceutical agents 
Medication overdose and poisoning have most commonly been reported from cities in 
the developing world [2, 3, 29]. Outside the cities, these poisonings are relatively 
uncommon. In general, overdoses of pharmaceuticals have a relatively good prognosis, 
particularly when compared to pesticides. While barbiturates were an extremely 
common means of self-poisoning worldwide during the 1970s [30, 31], 
benzodiazepines, antiepileptics, antidepressants and other psychoactive drugs are much 
more frequently reported today.  
Of the analgesic drugs, paracetamol (acetaminophen) is a common poison in some 
regions of the developing world. Papers on paracetamol poisoning have been reported 
from Hong Kong [32], Malaysia [33] and Taiwan [34].  
Herbal or traditional medicines 
Traditional Chinese medications of various forms have been reported to be commonly 
used for self-poisoning in Hong Kong and Taiwan [35, 36].  
Household products 
There have been few studies looking at domestic chemicals, but in some African and 
Asian communities they have been reported to constitute a major health problem [37, 
38]. Household products include for example kerosene oil used for lighting, agents for 
cleaning and bleaching, and strong acids and alkalis used for drain clearing.  
 4 
Kerosene is a common household energy source throughout the developing world, 
often kept in unsafe non-child-proof containers. These products are a major problem 
because of accidental poisoning among young children [39] and to a lesser extent, due 
to self-poisoning by adults. Pulmonary complications and deaths may result from their 
aspiration.  
Of other substances, potassium permanganate is a common household disinfectant that 
has been used for self-harm in Hong Kong  with fatal hepatorenal complications [40].  
Corrosives 
Corrosive chemicals are widely used in the industry and the homes. They cause intense 
damage to the pharynx, oesophagus and stomach, often producing perforations. Patients 
may die from peritonitis or mediastinitis, or from pulmonary complications such as 
fistula formation and pneumonia.  
This type of poisoning is quite different from other forms of acute poisoning. Patients 
poisoned by pesticides and pharmaceutical agents typically present with an acute crisis 
and if the course is not fatal, they will have few complications. In contrast, survivors of 
acute corrosive poisoning often require extensive surgical follow-up for their GI 
complications [41, 42].  
A Taiwanese group has reported their results after treating 75 patients for caustic 
oesophageal strictures or post-caustic resections over 15 years [43]. Most patients had 
taken HCl and all adults (62 patients) had taken the corrosive intentionally. Eitghty-
seven percent of the operations were done as elective procedures. There were no deaths 
and the outcome after these complicated procedures was described as ‘good’ in 90% of 
the cases.  
A large series of patients poisoned by domestic chemicals has been reported from 
Malaysia of whom the majority had ingested NaOH [44]. Again complicated bowel 
surgery procedures were required after the acute resuscitation. Ten patients died 
acutely, 11 required replacement surgery.  
Natural toxins 
Plants 
Poisonous plants have been used for centuries for homicide, suicide and inducing 
abortion [45]. Ingestion of some plants have become locally popular methods for self-
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harm, but none so serious and life threatening as the remarkable epidemic of yellow 
oleander seed poisoning currently occurring in Sri Lanka [46].  
Poisonous animals 
Snake-bites are well-known medical emergencies in many parts of the world, 
especially in rural areas. Agricultural workers and children are the most affected. The 
snake-bite mortality rate is particularly high in South-East Asia [47]. It is clear that in 
many parts of the South East Asian region, snakebite is an important medical 
emergency and cause of hospital admission. It results in the death or chronic 
disability of many active young people, especially those involved in farming and 
plantation work. However, the exact magnitude or the true rate of mortality and acute 
and chronic morbidity from snake-bite remains uncertain, because of inadequate 
reporting from almost every part of the region. Moreover, despite its importance, 
there have been few proper clinical studies of snake-bite compared to almost all other 
tropical diseases.  
Hymenopterans, as for example wasps, constitute a biologically extremely fascinating 
animal group due to their omnipresence in practically every living space and to the fact 
that they comprise the medically most significant venomous animals in the world. In 
the US and also in Europe, hymenopteran stings are the cause of the majority of deaths 
due to venomous animals [48].   
 
1.2 BUNGARUS MULTICINCTUS ENVENOMATION 
1.2.1 Medically important venomous snakes in Vietnam  
Snakebite is a largely unrecognized public health problem that causes significant 
challenges for medical management, especially in the tropical region [49]. In Vietnam, 
two snake families have poisonous members, the Elapidae and the Viperidae. The 
family Elapidae includes the king cobra (Ophiophagus hannah), the familiar cobras 
(Chinese/Taiwan cobra-Naja atra, monocellate cobra-N. kaouthia, and Thai or Isan 
spitting cobra-N. siamensis), and the kraits (Bugarus multicinctus, B. candidus, and B 
fasciatus). Among these venomous species, Ophiophagus Hannah, Naja atra and 
especially Bugarus multicinctus are responsible for many bites and much morbidity and 
mortalitty in northern Vietnam. Besides cobras and kraits, there are some sea venomous 
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snakes found along the coast of Vietnam, especially 3 species, namely: Hydrophis 
cyanocinctus, Lapemis hardwickii and Enhydrina schistose. The vipers (family 
viperidae) include some species: Calloselasma rhodostoma, Trimeresurus albolabris, 
T. popeiorum, and T. wagleri.  
1.2.2 Bugarus multicinctus and its geographical distribution 
The elapid snakes include, among others, the kraits represented by 12 species 
worldwide within the single genus Bungarus. The kraits are generally unagressive 
nocturnal animals that frequently enter rural houses. B. multicinctus (Chinese or many-
banded krait) are found in many Asian countries, including southern China, Taiwan, 
Hong Kong, and the northern parts of Laos, Myanmar, and Vietnam [49]. Its habitats 
include low plains and hilly regions up to an altitude of 1,300 meters.  Along the back 
of this snake is a series of black to bluish-black saddle-shaped markings separated by 
30-50 narrow white bands sprinkled with dark spot. The belly is pure white. The 
maximum length is 1.84 meters [49] (Fig. 1).  
 
 
Figure 1. Bungarus multicinctus. 
1.2.3 Venoms of B. multicinctus 
Snake venoms contain a large variety of enzymes (proteases, phospholipases, etc), 
non-enzymatic polypeptide toxins (post-synaptic neurotoxins, cardiotoxins etc), 
amino acids, biogenic amines, carbohydrates, lipids, nucleosides, nucleotides and 
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metals. Most of these components have no obvious role in the pathogenesis of 
envenoming in human patients. 
The most important and best known effects of B. multicinctus venoms are neurotoxic 
activities. Neurotoxicity has been defined as “a structural change or a functional 
adverse response of the nervous system to a chemical, biological or physical agent” 
[50]. In B. multicinctus venoms, the following classes of neurotoxins have been 
identified:  
α - bungarotoxin (Postsynaptically active toxin - toxin binding selectively to nicotinic 
acetylcholine receptors) 
The α-bungarotoxin, a “three finger” protein, has been extremely well-characterized.  
This postsynaptically active toxin binds (essentially irreversibly) selectively to 
peripheral nicotinic acetylcholine receptors (AChR ) at the postsynaptic membrane of 
the neuromuscular junction and prevent the binding of acetylcholine. The effect is to 
produce a non-depolarising type of neuromuscular blockade. This toxin, conveniently 
known as α-neurotoxin, has been an invaluable tool in the study of the nicotinic 
acetylcholine receptor [51].  
Envenoming bites by snakes whose venoms are rich in α-neurotoxins cause a 
neuromuscular weakness with very rapid onset and of potentially fatal depth. 
Reversal of paralysis, even in severely envenomed victims, occurs approximately 24 
hours after the bite, provided respiration is maintained, and recovery can be 
accelerated by the administration of antivenom or anticholinesterase [51]. The 
postsynaptic toxins that bind to nicotinic AChR cause no structural damage to any 
part of the nervous system or its target cell and any long-term sequelae to the bite 
must be considered due to the presence of other toxic fractions in the crude venom or 
a consequence of other types of complications. 
 β - bungarotoxin (Presynaptically active toxin - toxic phospholipases A2) 
Phospholipases A2 (PLA2) are common components of snake venoms. Snake venom 
phospholipases A2 fall into two major classes. Class I phospholipases A2 may be 
isolated from the venoms of elapid snakes and their close relatives the sea snakes. 
Class II phospholipases A2 may be isolated from venoms of viperid and crotalid 
snakes. Class I phospholipases A2 are homologous with pancreatic phospholipases 
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A2. Class II phospholipases A2 are homologous with the phospholipases A2 of 
platelets, neutrophils, and other cell types. 
The venom glands of snakes are derived from salivary glands, and so it is not 
unreasonable to suppose that the primary purpose of venom phospholipases is 
digestive. Snakes cannot chew their prey. Prey items are swallowed whole and so the 
ability to inoculate into a prey item a highly active phospholipase provides a means 
whereby the digestive process can begin very early. But, although the venom 
phospholipases A2 may originally have been purely digestive in function, many 
possess a wide range of other activities. They may, for example, be anticoagulant, 
cytotoxic, haemolytic, neurotoxic or myotoxic. This thesis is primarily concerned the 
neurotoxic and myotoxic activities of the toxic phospholipases A2. 
The neurotoxic phospholipases A2 are commonly referred to as β-neurotoxins to 
distinguish them from the α-neurotoxins, which bind to junctional nicotinic AChR at 
the vertebrate neuromuscular junction. The β-neurotoxins are presynaptically active, 
inducing neuromuscular weakness by attacking the motor-nerve terminal. 
Chang and Lee (1963) were the first to isolate and pharmacologically characterize the 
β-bungarotoxin from the venom of the Taiwan banded krait, Bungarus multicinctus. 
However, it was not until 1978 that the structure and amino acid sequence of β-
bungarotoxin was analysed in detail. It is a basic protein, with a molecular weight of 
21,800 kD consisting of two dissimilar polypeptide subunits [52]. A phospholipase 
A2 subunit named the A-chain and a non-phospholipase A2 subunit named the B-
chain that is homologous to bovine pancreatic trypsin inhibitor.  
Failure of neuromuscular transmission caused by neurotoxic phospholipases 
Studies on β-bungarotoxin have shown beyond doubt that the target for the neurotoxic 
phospholipases A2 is the nerve terminal rather than the axon of the motor neuron. The 
definitive evidence for this is that, at the cessation of spontaneous respiration following 
poisoning by β-bungarotoxin, electrical discharges can still be recorded from the 
phrenic nerve [52]. This simple observation demonstrates that fatal poisoning involves 
neither damage to the lower motor neuron nor the impairment of axonal conduction of 
the action potential. There is also extensive evidence that the presynaptically active 
neurotoxic phospholipases A2 do not block AChR on the postsynaptic surface of the 
neuromuscular junction [53].   
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1.2.4 Clinical manifestations of B. multicinctus envenoming  
The clinical characteristics arising from bites by Bungarus multicinctus (many-banded 
krait, Chinese krait) have rarely been described [54, 55]. This species is an important 
cause of snakebite mortality in Southern China. In Guangxi Zhuang autonomous region 
(close to the northern border of Vietnam), 8.4% of snakebites were caused by B. 
multicinctus and, 36.3% of these developed paralytic symptoms. The mortality rate was 
10% [56]. In Taiwan, 8% of bites were caused by this species between 1904 and 1971 
with a 23% case fatality rate [49]. Bites occur mainly at night time, but only 16% were 
inflicted in the home [56]. Local symptoms are negligible. The bite is felt as a prick 
followed by slight itching, numbness or redness but with minimal swelling. Nausea and 
vomiting may develop about 30 minutes later and neurotoxic symptoms within 1-4 
hours after the bite. These include ptosis, inability to speak and swallow, “trimus” 
(inability to open the mouth), chest tightness, breathlessness, generalized aching and 
weakness of the limbs. Other symptoms include headache, dizziness, thirst, confusion, 
throat pain, laryngeal spasm and drowsiness. In fatal cases not treated with antivenom, 
the interval between bite and death ranges from 6-23 hours [49].      
In northern Vietnam B. multicinctus is the only krait species of medical significance in 
humans [57]. Knowledge of the clinical features of envenomation by this snake is 
important for early diagnosis of severe conditions and for effective treatment of the 
snakebite. The symptoms are commonly observed as follows:  
Local symptoms and signs at the bitten part of the body: 
Envenomation by this krait produces no or only minimal local symptoms, except fang 
marks (Fig. 2). 
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Figure 2. Fang mark after a bite by Bungarus multicinctus. 
Systemic symptoms and signs:  
Neurological manifestations include paraesthesia, throat pain, ptosis (Fig. 3), external 
ophthalmoplegia, mydriasis (Fig. 4), paralysis of facial muscles and other muscles 
innervated by the cranial nerves, nasal voice or aphonia, regurgitation through the 
nose, difficulty in swallowing secretions, generalized aching, respiratory and 
generalized flaccid paralysis (Fig. 5), and parasympathetic abnormalities. Non-
neurotoxic complications include conjunctivitis, and ventilator associated pneumonia.   
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Figure 3. Ptosis after a bite by Bungarus multicinctus. 
 
 
Figure 4. Persistent mydriasis one year after envenomation by Bungarus multicinctus. 
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Figure 5. Respiratory and generalised flaccid paralysis after a bite by the later killed 
krait placed on the patient. 
 
1.3 ANTIVENOM THERAPY FOR ENVENOMATION BY BUNGARUS 
MULTICINCTUS 
 
Supportive care is an important part of the management of snakebites, but antivenom 
administration is the mainstay therapy in the majority of medically significant cases of 
envenomation. Such specific therapy may dramatically reduce the consequences of the 
envenomation [58-60]. Although antivenoms against B. multicinctus are available in 
China and Taiwan, clinical reports regarding their efficacy have only rarely been 
published [54, 56, 61]. In some series of cases antivenom treatment has been tried after 
snakebites by other Bungarus species, but with rather conflicting clinical results [62, 
63]. In Vietnam, no specific antivenom against B. multicinctus has been available until 
recently, when it was developed and produced for clinical use. The indication for 
antivenom administration in patients envenomed by B. multicinctus is the development 
of neurotoxic signs (Table 1).  
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Table 1. Indications for antivenom treatment after snakebite [47]  
Antivenom treatment is recommended if and when a patient with proven or suspected 
snake-bite develops one or more of the following signs: 
Systemic envenoming 
• Haemostatic abnormalities: Spontaneous systemic bleeding (clinical), 
coagulopathy (20WBCT or other laboratory tests such as prothrombin time) 
or thrombocytopenia (<100 x 109/litre or 100 000/cu mm) (laboratory). 
• Neurotoxic signs: ptosis, external ophthalmoplegia, paralysis etc (clinical).
• Cardiovascular abnormalities: hypotension, shock, cardiac arrhythmia 
(clinical), abnormal ECG. 
• Acute kidney injury (renal failure): oliguria/anuria (clinical), rising blood 
creatinine/ urea (laboratory). 
• (Haemoglobin-/myoglobin-uria:) dark brown urine (clinical), urine dipsticks, 
other evidence of intravascular haemolysis or generalised rhabdomyolysis 
(muscle aches and pains, hyperkalaemia) (clinical, laboratory).  
• Supporting laboratory evidence of systemic envenoming (see above). 
Local envenoming 
• Local swelling involving more than half of the bitten limb (in the absence of a 
tourniquet) within 48 hours of the bite. Swelling after bites on the digits (toes 
and especially fingers). 
• Rapid extension of swelling (for example, beyond the wrist or ankle within a 
few hours of bite on the hands or feet). 
• Development of an enlarged tender lymph node draining the bitten limb 
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Antivenom adverse reactions 
A proportion of patients, usually more than 10%, develop a reaction either early 
(within a few hours) or late (five days or more) after being given antivenom. The risk 
of reactions is dose-related, except in rare cases in which there has been sensitization 
(IgE-mediated Type I hypersensitivity) by previous exposure to animal serum, for 
example, to equine antivenom, tetanus-immune globulin or rabies-immune globulin. 
(1) Early anaphylactic reactions: Usually within 10-180 minutes of starting 
antivenom administration, the patient begins to itch (often over the scalp) and 
develops urticaria, dry cough, fever, nausea, vomiting, abdominal colic, diarrhoea and 
tachycardia. A minority of these patients may develop severe life-threatening 
anaphylaxis: hypotension, bronchospasm and angio-oedema. Fatal reactions have 
probably been under-reported as death after snake-bite is usually attributed to the 
venom and patients may not be monitored carefully after treatment. In most cases, 
these reactions are not truly “allergic”. They are not IgE-mediated type I 
hypersensitivity reactions to horse proteins as there is no evidence of specific IgE, 
either by skin testing or radioallergosorbent tests (RAST). Complement activation by 
IgG aggregates or residual Fc fragments or direct stimulation of mast cells or 
basophils by antivenom protein are more likely mechanisms for these reactions. 
(2) Pyrogenic (endotoxin) reactions: These reactions usaully develop 1-2 hours after 
treatment. The symptoms include shaking chills (rigors), fever, vasodilatation and 
hypotension. Febrile convulsions may be precipitated in children. These reactions are 
caused by pyrogenic contamination during the manufacturing process. They are 
commonly reported. 
(3) Late (serum sickness type) reactions: These adverse reactions develop 1-12 
(mean 7) days after treatment. Clinical features include fever, nausea, vomiting, 
diarrhoea, itching, recurrent urticaria, arthralgia, myalgia, lymphadenopathy, 
periarticular swellings, mononeuritis multiplex, proteinuria with immune complex 
nephritis and, rarely, encephalopathy. Patients who suffer early adverse reactions and 
are promptly treated with antihistamines and corticosteroid are less likely to develop 
late reactions. 
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Treatment of antivenom adverse reactions [47] 
Early anaphylactic and pyrogenic antivenom reactions: Epinephrine (adrenaline) is 
given intramuscularly (into upper lateral thigh) in an initial dose of 0.5 mg for adults 
and 0.01 mg/kg body weight for children. As severe, life-threatening anaphylaxis may 
evolve rapidly, epinephrine (adrenaline) should be given at the very first sign of a 
reaction, even when only a few spots of urticaria have appeared or at the start of 
itching, tachycardia or restlessness. The dose can be repeated every 5-10 minutes if 
the patient’s condition is deteriorating. 
Additional treatment: After epinephrine (adrenaline), an antihistamine, such as 
chlorphenamine, should be given IV followed by intravenous hydrocortisone. The 
corticosteroid is unlikely to act for several hours, but may prevent recurrent 
anaphylaxis. 
In pyrogenic reactions the patient must also be cooled physically and with 
antipyretics. Intravenous fluids should be given to correct a relative hypovolaemia. 
Treatment of late (serum sickness) reactions: Late adverse reactions may respond to 
a 5-day course of oral antihistamine. Patients who fail to respond in 24-48 hours 
should be given a 5-day course of a corticosteroid. 
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2 AIMS  
Poisoning is a major health problem in northern Vietnam. The principal aims of these 
studies were to improve prevention, differential diagnosis and treatment of this threat 
to the public. 
 
2.1 SPECIFIC AIMS FOR PAPER I 
To investigate the poisoning pattern in northern Vietnam by studying the frequency and 
characteristics of poisoning emergencies admitted to the only Poison Control Center 
(PCC) in Vietnam during its first five years (1999 – 2003). 
 
2.2 SPECIFIC AIMS FOR PAPER II 
To assess the frequency and clinical features of patients admitted to the PCC in Hanoi 
during 2000 – 2003 after envenomation by Bungarus multicinctus. 
 
2.3 SPECIFIC AIMS FOR PAPER III 
To assess the efficacy of a newly produced antivenom against Bungarus multicinctus 
and to investigate its possible side effects. 
 
2.4 SPECIFIC AIMS FOR PAPER IV 
To identify the most commonly occurring toxin exposure hazards and other risks of 
acute poisoning in the rural area of northern Vietnam. 
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3 METHODS 
3.1 METHODS FOR PAPER I 
In this retrospective study, the medical records of all patients admitted to the PCC in 
Hanoi during the years 1999 and 2003 because of poisoning were carefully reviewed.  
Poisoning was defined as drug overdose, food poisoning, or exposure to any 
environmental toxic substance. A study protocol was developed from the existing 
IPCS-Case/Incident/Request Format (http://www.who.int/ipcs/poisons/Minform-
Eng.XLS)[64]. The protocol was subsequently refined and covered all pertinent data 
including demographics, type of poisoning, clinical findings, treatment, and outcome.  
The patients either presented directly to the PCC or were referred from other hospitals 
in northern Vietnam. The severity of each case of poisoning was defined upon 
admission, using the 5-graded Poisoning Severity Score (PSS) criteria of the IPCS [65]. 
The outcome in each patient was classified into one of three categories: 1. recovery, 2. 
sequela (an impairment of functioning corresponding to a performance category of 2-4 
on the 5-graded Glasgow-Pittsburgh Outcome Scale [66, 67] on discharge from 
hospital), or 3. death during hospitalization.  
 
3.2 METHODS FOR PAPER II 
In this retrospective study the medical records of all patients treated at the intensive 
care unit (ICU) of the PCC for envenoming by B. multicinctus during the 4-year period 
2000-2003 were carefully reviewed. In a majority of the cases, the type of snake was 
determined either at the hospital by investigation of a snake specimen brought to the 
PCC or by the patient in connection with the bite. In some cases the snake was never 
seen, however, and the diagnosis was then established by the circumstances of the bite 
together with the presence of typical clinical features. A predetermined study protocol 
was developed. Pertinent data of each case were recorded, including demographics, the 
time and circumstances of the bite, the body parts bitten, symptoms and signs, 
laboratory findings, any complications, length of time spent in the ICU, and the 
outcome. The severity of each case was defined using the 5-graded (0-4) Poisoning 
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Severity Score (PSS) [65]. Treatment measures documented in the medical records, 
such as mechanical ventilation, were also noted.  
 
3.3 METHODS FOR PAPER III 
This prospective controlled clinical trial was carried out during a three-year period 
(2004-2006) at the ICU of the PCC at Bach Mai Hospital in Hanoi. For ethical reasons 
and because the antivenom was not clinically available until 2006, the study was not 
randomized or blinded. All patients who fulfilled the inclusion criteria during the first 
two years of the study were prospectively enrolled, carefully monitored and treated 
with optimal supportive therapy in the ICU (control group). The patients who entered 
the study during the third year were treated with antivenom therapy in addition to 
supportive care (antivenom group). The patients were enrolled on the basis of the 
following criteria: 1. envenomation by B. multicinctus, 2. presence of clinical signs of 
systemic envenomation (neuromuscular signs), and 3. (during the year 2006) provision 
of written informed consent (by close relative if the patient was unable to do so). 
Clinical data including a number of defined clinical and laboratory examinations, were 
recorded for each case in a predetermined standardized protocol during the entire 3-
year study period. The severity of the symptoms on recruitment was defined on the 
basis of the 5-graded (0-4) Poisoning Severity Score (PSS) [65].  
During the year 2006, the patients were informed about the possible benefits and risks 
of the antivenom treatment and were able to withdraw at any time during the trial for 
any reason. Five to ten ampoules of antivenom, depending on the severity of muscle 
paralysis, were diluted with isotonic glucose solution to a total of 50 ml and then 
infused intravenously by electric pump during a period of one hour. The patients were 
monitored continuously during and after the infusion to assess the efficacy of the 
treatment and any adverse reactions. Six to 8 hours after the end of the infusion, a 
second infusion was administered, under similar conditions, if no clinical improvement 
or adverse reaction had been noted. Clinical examinations, in accordance with the study 
protocol, were performed at least twice daily up to discharge. The patients were also 
followed up one month later and readmitted if associated symptoms developed or 
became worse.   
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Predefined outcome endpoints were number of patients requiring mechanical 
ventilation, duration of mechanical ventilation, length of stay in the ICU, duration of a 
defined degree of muscle paralysis, and number of patients who developed a ventilator-
associated pneumonia. The study was conducted in accordance with the WHO Good 
Clinical Practice guidelines and the Declaration of Helsinki. The study design and the 
form for the written consent were approved by the Ethics Committee of Hanoi Medical 
University.  
Antivenom 
Venom pools from more than 100 specimens of B. candidus and B. multicinctus of 
different sizes, ages and sexes were collected from Vietnam. After milking, venoms 
were immediately lyophilized and then detoxified with glutaraldehyde, filtered, and 
stored at 4°C in bottles. Immunization of horses with increasing doses of the antigen 
described above was performed once a month for 7 months. The immunoglobulin 
fraction from each of the pooled horse plasma samples was pepsin-digested and then 
salt-precipitated to produce F(ab’)2 fragments. The antivenom was supplied in liquid 
form, 2000 units per ampoule. The antivenom was approved for the use under 
discussion in the manuscript by the National Institute for Control of Medico Biological 
Products, Ministry of Health in Vietnam, but it has not yet become a commercial 
product.   
 
3.4 METHODS FOR PAPER IV 
This cross-sectional population-based epidemiological study was conducted in the Phu 
Tho province in northern Vietnam during the year 2008. This province is situated at the 
apex of the Red river delta linking Hanoi with the Northern mountainous provinces 
(Fig. 6). Its area is 3,519 km2, corresponding to 1% of the whole country, and its 
population in the year 2006 was about 1.3 million or approximately 1.5% of all 
Vietnamese. The rural population of Phu Tho accounts for 85% of its total inhabitants, 
a proportion which resembles that of entire Vietnam. There are 13 local administrative 
regions (11 districts, one city, and one township) in the Phu Tho province, comprising a 
total of 273 communes. Among these, two out of twelve communes in the Lam Thao 
district were chosen as the study setting. The inhabitants of these two communes are 
representative of Vietnam regarding occupational distribution and the communes are 
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typical of Vietnam regarding density of population and nature of agriculture. The main 
crops in the study area are rice and different kinds of vegetables, just as in the main 
parts of rural Vietnam. 
 
Fig 6. Map of Vietnam and Phu Tho province 
 
The study population initially comprised 1,000 randomly selected households in the 
two above mentioned communes, which consisted of 23 villages. After giving their 
informed consent, 942 households comprising 3,814 individuals, were finally enrolled 
in the study. The data collection methods included face-to-face interviews, using a 
structured questionnaire, and reality observations following a structured checklist. The 
questionnaire covered information on demographic features and on general 
epidemiological points, poisoning events, and risk factors for poisoning. Poisoning was 
defined as drug overdose, food poisoning, or any symptomatic exposure to an 
environmental toxic substance. The checklist included presence of any pesticides, other 
toxic chemicals, pharmaceuticals, or drugs of abuse at home, and also safety keeping 
methods, equipment for preparation and use of pesticides, and existence of poisonous 
plants or animals.  
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4 RESULTS 
4.1 EPIDEMIOLOGY OF POISONING IN NORTHERN VIETNAM 
4.1.1 Frequency, characteristics and management of poisoning 
emergencies admitted to the PCC in Hanoi during its first 5 years 
(paper I)  
The annual number of admitted poisoned patients increased during the initial period of 
the first PCC in Vietnam, from 313 in 1999 (59.5% of the total number of admissions) 
to  1,523 in 2003 (91.3% of all admissions). The female : male ratio during the five-
year period was approximately 1:1. The largest number of poisoned patients was found 
in the age-group 15-24 years.  
In the year 1999, unemployed persons and agricultural workers were the most common 
occupational groups among the poisoned patients. Four years later, students and people 
working in service occupations increased dramatically (Table 2). A finding that did not 
change during the 5-year period was that a vast majority of the toxic exposures 
occurred at home (74.1%). 
 
Table 2. Occupational distributions of the poisoned patients during the years 1999 and 
2003. 
Occupation 
1999, n=313 2003, n=1523 Total, n=1836 
n n n % 
Service occupations 57 474 531 28.9 
Student 54 358 412 22.4 
None 85 256 341 18.6 
Agricultural worker 82 250 332 18.1 
Industrial worker 24 160 184 10.0 
Other or unknown 11  20  36   2.0 
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Concerning the types of toxic agents causing the poisoning, the most common in 
1999 were pharmaceuticals and pesticides. In 2003 food poisoning predominated, 
followed by pharmaceuticals, toxins from poisonous animals (mostly snake 
venom), and pesticides (Table 3).   
The clearly predominating route of exposure was ingestion. Bites and stings from 
poisonous animals were also relatively common. Injection of heroin and inhalation 
of toxic gases were examples of less common routes of exposure (Table 4). 
 
Table 3. Types of toxic agents involved in the cases of poisoning. 
Type of toxin 
1999, n=313 2003, n=1523 Total, n=1836 
n n n % 
Food/beverage   19 626 645 35.1 
Pharmaceuticals  160 460 620 33.8 
Poisonous animals (mostly snakes)   29 202 231 12.6 
Pesticides (including rodenticides)   61 107 168   9.1 
Drug of abuse (heroin)   13   72   85   4.6 
Household/leisure products     6   12   18   1.0 
Industrial / commercial products     8     7   15   0.8 
Environmental contamination     1     9   10   0.5 
Plants     3     6     9   0.5 
Other or unknown   13   22   35   1.9 
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Table 4. Routes of exposure among the poisoned patients during the years 1999 and 
2003. 
Route of exposure 
1999, n=313 2003, n=1523 Total, n=1836 
n n n % 
Ingestion 269 1190 1459 78.6 
Bite   28   133   161   8.8 
Sting     0     64     64   3.5 
Injection     8     53     61   3.3 
Inhalation     5     29     34   1.8 
Cutaneous     0       7       7   0.4 
Other or unknown     3     47     50   2.7 
 
Compared with accidental toxic exposures, the number of deliberate poisonings 
was larger in 1999 but smaller during 2003. In total, these two types of the toxic 
exposure were approximately equally common. Suicidal poisoning constituted 
approximately one third of all cases of poisoning (Table 5). 
 
Table 5. Intentional versus unintentional poisoning.  
Circumstance of exposure 
1999, 
n=313 
2003, 
n=1523 
Total, n=1836
n n n % 
Unintentional (accidental)   82 823 905 49.3
Intentional-suicide 178 393 571 31.1
Intentional-misuse, abuse, malicious   34 234 268 14.6
Unknown   19   73   92   5.0
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A majority of the poisoned patients displayed mild symptoms (PSS grade 1) on 
admission to the PCC. However, more than a quarter of the total number of 
poisoned patients showed pronounced clinical signs of poisoning and some even 
had life-threatening symptoms. During the year 1999, the relative proportion of 
patients with severe poisoning (PSS grades 3-4) was higher than during 2003 
(16.9% and 8.9%, respectively, p<0.001) (Table 6).   
 
Table 6. Poisoning Severity Score (PSS) on admission to the PCC. 
Severity of poisoning 
(PSS) 
1999, n=313 2003, n=1523 Total, n=1836 
n n n % 
None (0) 58 77 135 7.4 
Minor (1) 163 1051 1214 66.1 
Moderate (2) 39 259 298 16.2 
Severe (3) 53 135 188 10.2 
Fatal (4) 0  1  1   0.1 
 
 
The occurrence of specified poisoning-induced symptoms recorded during the 
hospital stay is shown in Table 7. The most common signs of serious poisoning 
were a reduced level of consciousness, respiratory failure, hypotension, 
rhabdomyolysis, and seizures.  
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Table 7. The distribution of specified poisoning-induced symptoms recorded at the 
PCC. 
Poisoning-induced symptoms 
1999, 
n=313 
2003, 
n=1523 
  Total, 
n=1836    
n n n % 
Reduced level of consciousness* 83 235 318 17.3 
Respiratory failure 64   83 147   8.0 
Hypotension (systolic BP <90 mmHg) 33   96 129   7.0 
Rhabdomyolysis 12 111 123   6.7 
Seizures 15   73   88   4.8 
Bradycardia (heart rate <50)   5   28   33   1.8 
Ventricular arrhythmia† 13   19   32   1.7 
Acute renal failure 10   18   28   1.5 
Acute hepatic failure   3   16   19   1.0 
Gastrointestinal hemorrhage   2   15   17   0.9 
*Glasgow Coma Scale score <13 
†Including 26 patients with frequent ventricular extrasystoles and 6 with ventricular 
tachycardia. 
 
The poisoning specific-treatments most commonly used during the study years 
were decontamination measures such as administration of cathartics, activated 
charcoal, gastric lavage and skin decontamination. Intensive care measures such as 
mechanical ventilation and dialysis were used less frequently. Specific antidotes 
were given in approximately 5% of all cases (Table 8). 
 
 
 26 
Table 8. Use of therapeutic interventions in the poisoned patients at the PCC. 
Treatment 
1999, n=313 2003, n=1523 Total, n=1836 
n n n % 
Induced emesis   12   71   83   4.5 
Gastric lavage 191 364 555 30.2 
Charcoal, single dosage 143 437 580 31.6 
Charcoal, repeated dosage   46   25   71   3.8 
Cathartic 195 433 628 34.2 
Skin decontamination   23   66   89   4.8 
Irrigation of eye     4   12  16   0.9 
Endotracheal intubation   64   83 147   8.0 
Mechanical ventilation   56   64 120   6.5 
Antidote administration   16   80   96   5.2 
Hemodialysis     8   23   31   1.7 
 
 
The mean stay in the PCC was 2.10 ± 0.99 days. Of the total of 1,836 poisoned 
patients, 1,322 (72.1%) were discharged within 24 hours. However, 140 patients 
(7.6%) required hospitalization for more than one week. The longest treatment 
duration was 62 days. 
 
The main outcome among the poisoned patients treated at the PCC during 1999 and 
2003 is shown in Table 9. The hospital mortality rate was higher in 1999 (1.9%) than 
during 2003 (1%), but the difference was not statistically significant. The fatalities 
mainly resulted from poisoning by hypnotic pharmaceuticals (phenobarbital in 5 cases), 
heroin overdose and some very toxic pesticides.  
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Table 9. Main outcome among the cases of poisoning at the PCC. 
Main outcome 
1999, n=313 2003, n=1523 Total, n=1836 
n n n % 
Recovery 306 1499 1805 98.3 
Sequela     1       9     10   0.5 
Fatal     6     15     21   1.1 
 
4.1.2 Potentially hazardous environmental factors for poisoning in rural 
Vietnam (paper IV)  
Among the total study population of 3,814 persons, 1,921 or 50.4% were male. Their 
mean age was 32.7 ± 19.7 (range 1 - 94) years. The study population consisted of 942 
families (households). The mean number of family members was 4.0 + 1.2 (range 1-8) 
people. A majority of the study population were agricultural workers. Other common 
occupations were students, industrial laborers, and commercial workers (Table 10).  
Table 10. The occupational distribution of the study population.  
Occupation n (%)
Agricultural worker 1,981 (51.9)
Student 917 (24.0)
Industrial worker 332 (8.7)
None 254 (6.7)
Commercial worker 97 (2.5)
Small children  48 (1.3)
Housewife/husband 7 (0.2)
Other or unknown 178 (4.7)
Total 3,814 (100)
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Hazardous exposures to toxic agents commonly occurred. Pesticides and other 
chemicals used in agriculture were the most frequently involved toxic compounds 
(Table 11). 
 
Table 11. Occurrence of hazardous exposures to toxic agents.  
Toxic agent Household, n (%)
Insecticides 783 (83.1)
Herbicides 601 (63.8)
Household products  223 (23.7)
Rodenticides 202 (21.4)
Adulterant chemicals 23 (2.4)
Industrial chemicals 22 (2.3)
Preservation 
chemicals 
19 (2.0)
Toxic gases 1 (0.1)
 
Of the total study population, 438 individuals (11.5%) recalled having suffered from at 
least one symptomatic episode of acute poisoning. The toxic agents reported to be most 
commonly involved in these incidents were different kinds of pesticides (Table 12).   
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Table 12. Toxic agents reported to have been involved in the most recently occurring 
symptomatic poisoning episode among the study population. 
Toxic agent n (%)
Pesticides 301 (68.7)
Pollution 8 (1.8)
Other chemicals used in agriculture  5 (1.1)
Food poisoning 4 (0.9)
Industrial chemicals 2 (0.5)
Medications 1 (0.2)
Other or unrecognized 117 (26.7)
 
Among the studied households, 48 (5.1%) reported to have at least one family member 
with some chronic medical consequence of a poisoning. None of these sequelae was 
life-threatening, but rather graded was as mild to moderate. Examples of these chronic 
symptoms were general tiredness, and weakness and numbness of distal extremities. 
They were most commonly (71%) consequences of exposures to pesticides.  
Concerning the presence of toxic agents in the homes, different pesticides were again 
the most common. Other common toxic agents kept at home were chemical household 
products and other agrochemicals (Table 13). 
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Table 13. Toxic agents kept at home.  
Toxic agent Presence in household, n (%)
Insecticides 294 (31.2)
Chemical household products  274 (29.1)
Herbicides 44 (4.7)
Rodenticides 21 (2.2)
Adulterant chemicals 6 (0.6)
Industrial chemicals 4 (0.4)
Preservation chemicals 3 (0.3)
Other toxic chemicals 119 (12.6)
 
A majority of the households had obtained knowledge of safety keeping processes 
directly from sellers. Only in barely one third of the households had the family 
members received the necessary knowledge from responsible persons such as 
agricultural expand personnel. Approximately 7% of the households had not been given 
any information concerning safety keeping methods at all (Table 14). 
Table 14. Sources of information concerning methods of safety keeping of toxic agents 
at home. 
Source of information Households, n (%)
Sellers 479 (50.8)
Agriculture expand personnel 303 (30.2)
Self-learning from other sources 293 (31.1)
Media   275 (29.2)
Relatives, friends, neighbors  97 (10.3)
None 66 (7.0)
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Among the studied households, 204 (21.7%) reported that they had kept poisonous 
chemicals in places accessible to children, and 505 (53.6%) had never locked chemical 
storage boxes or drawers. One hundred and thirty-one households (13.9%) had not kept 
hazardous chemicals in their original containers, and among these 33 (3.5%) had used 
food containers to keep poisonous chemicals. More than a fourth of the households 
(27.7%) did not have the habit of explaining to their children about the risks with toxic 
chemicals. 
The risk of overdosage of pharmaceuticals was also recorded in the study. Nearly half 
of the households always kept medications at home, but only approximately one fourth 
had any medical safe-box. A large proportion of the households (56.2%) reported that 
prescriptions were not necessary for purchasing pharmaceuticals. 
Some common habits of the studied households put their members in danger of 
poisoning by natural toxins. Among these, frequent use of herbs, and raising and eating 
poisonous animals, were the most important hazardous practices (Table 15).  
    
Table 15. Possible risk factors for natural toxin poisoning.  
Possible risk Households, n (%) 
Collection and ingestion of unusual herbs*  292 (30.1) 
Use of poisonous animals as food 241 (25.6) 
Honey collection from bee and wasp nests 125 (13.3) 
Raising poisonous animals  86 (9.1) 
Ingestion of animal gallbladders 30 (3.2) 
*After advice from quacks in approximately half of the households. 
When observing the reality with their own eyes, the interviewers found that pesticides 
were present in 369 of the households (39%). Pesticides were most commonly kept in 
containers without any lock (97.5%). The presence of pharmaceuticals at home was 
observed in 564 households (60%). Besides bees’ nests, which were common, 
venomous snakes were seen to be raised in 75 of the households and poisonous toads in 
14.     
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4.2 IMPORTANT POISONING – ENVENOMING BY B. MULTICINCTUS  
4.2.1 Clinical features of 60 patients envenomed by B. multicinctus 
(paper II) 
A total of 60 consecutive cases admitted to the PCC in Hanoi during the 4-year study 
period for the treatment of envenoming by B. multicinctus were collected. Forty-six 
patients were male (77%) and 14 were female. Their mean age was 33.3 ± 13.5 years, 
ranging from 12 to 67 years. The most common occupational category among the 
patients were agricultural workers (57%).  
Most commonly the attack took place either at home or in the rice field (Table 16). The 
majority of the snakebites occurred during the night-time (Fig. 7). Thus, the snake was 
recognized in only 38 patients (63%). The body parts most commonly bitten were the 
hands and feet. 
 
Table 16. Site of the snake attack (n=60).  
Site n (%)
Home 21 (35)
Rice field 20 (33)
Village road 11 (18)
Ponds 5 (8)
Other 3 (5)
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69%
31%
8 pm ‐ 8 am
8 am ‐ 8 pm
 
Figure 7. The time of day of the snake attack. 
 
 
The mean time from the bite until the first symptom developed was 3.0 ± 3.6 hours, 
ranging from 0.5 to 24 hours. Most commonly the first manifestations were pharyngeal 
pain, ptosis, general myalgia, dyspnea, and dysphagia. According to the PSS criteria, 54 
patients (90%) were classified as having severe or lethal envenomation (PSS grades 3-
4), and only 3 patients (5%) displayed mild symptoms (PSS grade 1).  
The clinical manifestations of the snakebite were rather specific. Not one single patient 
had any local symptoms such as swelling or necrosis. Fang marks were noted in 54 
cases. The neuromuscular symptoms and signs most commonly observed during the 
stay at the ICU of the PCC were ptosis, mydriasis, ophthalmoplegia, jaw weakness, 
pharyngeal pain, palatal palsy, general myalgia, neck muscle paralysis, paralysis of the 
extremities (most pronounced proximally), absent or diminished tendon reflexes, 
paralysis of the respiratory muscles, urinary retention, and decreased bowel movement 
(Table 17). 
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Table 17. Neuromuscular symptoms and signs commonly recorded during the ICU stay 
(n=60). 
Neuromuscular symptoms and signs n (%)
Ptosis 56 (93)
Mydriasis 56 (93)
Proximal limb palsy 51 (85)
Distal limb palsy 46 (77)
Absent or diminished deep tendon reflexes 47 (78)
Ophthalmoplegia 49 (82)
Jaw paralysis 54 (90)
Palatal paralysis 54 (90)
Pharyngeal pain 50 (83)
Neck muscle paralysis 51 (85)
Diaphragmatic palsy 49 (82)
Intercostal muscle palsy 52 (87)
Dyspnea 52 (87)
General myalgia 41 (68)
Urine retention 40 (67)
Absent or decreased bowel movement 27 (45)
 
 
Respiratory failure was either a result of respiratory muscle paralysis and/or palatal 
paralysis leading to accumulation of secretion. The cardiovascular signs most often 
documented were tachycardia (defined as a heart rate faster than 100 beats per minute 
during > 6 hours the first two days) and hypertension (above 140/90 mmHg during > 6 
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hours the first 2 days). Conjunctivitis as a result of dry eyes was also commonly noted. 
Among the laboratory results, the most surprising was a high rate of significant 
hyponatremia (serum sodium level less than 130 mmol/L) (Table 18). When it 
occurred, this disturbance mostly developed during day 2 or day 3 after the snakebite.  
 
Table 18. Extra-neuromuscular symptoms and signs commonly recorded during the 
ICU stay (n=60). 
Symptoms and signs n (%)
Tachycardia 50 (83)
Hypertension 26 (43)
Conjunctivitis 41 (68)
Corneitis 1 (2)
Hyponatremia 25 (42)
 
The most commonly recorded complication was ventilator-associated pneumonia due 
to long-term mechanical ventilation; this was observed in 37 patients (62%). Other 
important complications documented were infection of the urinary tract (23 cases) and 
ileus (2 cases). No antivenom was available during the study period. Supportive care, 
especially mechanical ventilation, was therefore the main treatment given. Fifty-two of 
the patients in the study population had to be endotracheally intubated for this purpose. 
The duration of artificial ventilation averaged 8.2 ± 7.3 days, ranging from 1 to 29 days. 
A majority of the patients were also treated with antibiotics and sodium replacement as 
well as local ophthalmologic therapy (Table 19). 
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Table 19. The ICU management of the 60 envenomed patients. 
Treatments commonly given n (%)
Endotracheal intubation 52 (87)
Tracheotomy 2 (3)
Mechanical ventilation 52 (87)
Antibiotic therapy 40 (67)
Extra sodium replacement 40 (67)
Ophthalmologic therapy (vitamin A, antibiotics)  48 (80)
 
The mean duration of the ICU stay in the study population was 12 ± 9 days, ranging 
from 1 to 36 days. The hospital mortality rate was 7%. All 4 patients died in the ICU. 
Two of them died in connection with their admission to the ICU, another because of 
malfunction of a ventilator, and the fourth died of severe hyponatremia-induced brain 
damage. In addition, two patients suffered long-term sequelae. One had an anoxic brain 
injury and another became dependent on a tracheostomy cannula. 
 
4.2.2 Efficacy of a novel antivenom in patients envenomed by B. 
multicinctus (Paper III) 
During the 3-year study period, a total of 81 patients fulfilled the inclusion criteria and 
entered the controlled clinical trial. Of these, 54 patients were included during the years 
2004 and 2005 (control group) and 27 during 2006 (antivenom group). The baseline 
characteristics were similar in the two groups, and are presented in Table 20. Most 
patients were male and of a productive age. Children below the age of 15 years 
represented 14% of the study population, and elderly patients (>60 years) accounted for 
4%. Most of the patients developed their first symptoms within approximately 3 hours 
after the snakebite, and were admitted to the ICU later than 6 hours after the bite. All 
included patients displayed moderate or severe envenomation on admission according 
to the PSS criteria, with similar severity in the two groups. 
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Table 20. Baseline characteristics in the two study groups. 
Variables Control group Antivenom group Significance 
Age (years) 34 ± 15 36 ± 17 NS 
Sex   NS 
 Male 38 (70%) 18 (67%) 
 Female 16 (30%) 9 (33%) 
Time to development of first 
symptom  (hours) 
3.1 ± 2.7 2.7 ± 1.9 NS 
Duration from snakebite to 
admission (number of patients) 
  NS 
 Within 6 hours 13 (24%) 9 (33%) 
 > 6 hours 41 (76%) 18 (67%) 
Site of bite   NS 
 Limb 49 (91%) 25 (93%) 
 Trunk 3 (6%) 1 (4%) 
 Unknown 2 (4%) 1 (4%) 
Severity score on recruitment   NS 
 Moderate (PSS 2) 9 (17%) 4 (15%) 
 Severe (PSS 3) 45 (83%) 23 (85%) 
NS = not significant; PSS = Poisoning Severity Score12 
 
The time span between the snakebite and the start of antivenom therapy was 19 ± 9 
hours, ranging from 5 to 38 hours. Twenty patients were treated by antivenom within 
24 hours after the bite (only 2 patients within 6 hours). The average dose of 
administered antivenom was 8.1 ± 3.2 ampoules, ranging from 5 to 17 ampoules.  
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The patients in the antivenom group had a significantly shorter duration of paralysis of 
the extremities, the diaphragm, and of ptosis. Hyponatremia was a common finding in 
the study population. The proportion of patients with marked hyponatremia (serum 
sodium level of less than 130 mmol/L) was somewhat lower in the antivenom group, 
and severe hyponatremia (sodium level <120 mmol/L or symptomatic) was only 
observed in the control group (2 patients). The rate of ventilator-associated pneumonia 
was significantly lower in the antivenom group (Table 21).  
 
Table 21. A comparison between the two groups regarding some clinical findings 
during the stay in the intensive care unit. 
Clinical findings Control group Antivenom group Significance (p) 
Duration of limb paralysis (days) 7.5 ± 6.9 2.2 ± 2.6 <0.001 
Duration of diaphragm palsy (days) 7.0 + 7.0 1.6 + 1.6 <0.001 
Duration of ptosis (days) 6.3 ± 4.7 3.5 ± 1.5 <0.001 
Hyponatremia with serum Na <130 
mmol/L (number of patients) 
27 (50%) 9 (33%) 0.16 
Ventilator-associated pneumonia 
(number of patients) 
27 (50%) 6 (22%) 0.02 
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Table 22 presents the treatment measures in the two groups. There was no fatality. The 
relative numbers of patients requiring endotracheal intubation and mechanical 
ventilation were similar in the two groups. However, the duration of mechanical 
ventilation and endotracheal intubation, and the length of the ICU stay were 
significantly shorter in the antivenom group. No treatment with any cholinesterase 
inhibitor was given during the 3-year study period. 
In the seven patients treated with antivenom later than 24 hours after the snakebite, the 
duration of mechanical ventilation and the length of the ICU stay were longer than 
those in the 20 patients who received antivenom within 24 hours (Mann-Whitney test, p 
values 0.07 and 0.01, respectively).  
No patient in the study developed severe acute anaphylaxis. The rate of adverse 
reactions was 7.4% (2/27). A moderate allergic reaction in the form of urticaria was 
noted in one patient. Liver transaminase levels were transiently increased in another 
patient, in whom the maximum values of aspartate transaminase (AST) and alanine 
transaminase (ALT) were observed on the fifth day (344 and 442 U/L, respectively, or 
approximately 10 times the upper reference levels). Serum sickness was not observed 
in the study. Among the patients in the control group, none developed any allergic 
reaction and none had significantly but transiently elevated liver enzymes. 
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Table 22. A comparison between the two groups regarding some treatment measures 
during the intensive care unit (ICU) stay. 
 
Outcome measures Control group Antivenom group Significance (p) 
Duration of mechanical 
ventilation  (days) 
  <0.001 
 Mean (±SD) 8.6 ± 8.1 2.3 ± 2.5 
 Range 0 - 31 0 - 12 
Duration of intubation (days)   <0.001 
 Mean (±SD) 10.1 ± 9.3 3.0 ± 2.6 
 Range 0 - 40 0 - 12 
Length of ICU stay (days)   <0.001 
 Mean (±SD) 11.6 ± 9.7 6.1 ± 3.2 
 Range 1 - 46 1 - 15 
Number of patients requiring 
mechanical ventilation 
44 (81.5%) 23 (85.2%) NS 
NS = not significant. 
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5 DISCUSSION 
5.1 FREQUENCY, CHARACTERISTICS AND MANAGEMENT OF 
POISONING EMERGENCIES (PAPER I) 
The annual number of admitted cases of poisoning increased rapidly during the initial 
years of the first PCC in Vietnam. Similar findings were reported from Thailand during 
the same period [3], and probably reflect an increasing awareness of the existence of 
the PCC among members of the medical society and the population at large. Another 
explanation may be an increasing awareness of the need of specialized care of these 
emergencies. 
The study result established that the clearly most common location of the toxic 
exposures was the patient’s home. This finding may provide a basis for intervention 
measures and steps towards an improved poisoning prevention strategy in Vietnam. 
Among underlying toxic agents, the heterogeneous group “food poisoning” was found 
to be the most frequent. Pharmaceuticals constituted the second most common group, 
in conformity with the general pattern of poisoning in the USA and Europe, as well as 
in developing countries [2, 68]. In Vietnam, medications are readily accessible as a 
consequence of a lack of regulations, which is a great problem, especially concerning 
suicidal patients and children. This fact constitutes another important issue for the 
health care system and the government in Vietnam to consider in their attempts to 
prevent poisoning.    
Pesticides have been identified as the agents responsible for a majority of deaths from 
poisoning in developing countries [3, 29]. A study in Zimbabwe showed that pesticides 
accounted for the largest proportion of deaths from poisoning at both district and 
provincial hospitals, indicating that mortality from pesticides is a problem both in urban 
and rural areas [69]. In a study in Sri Lanka it was found that easily available pesticides 
in rural areas, economic problems and family conflicts were the main underlying causes 
of intentional pesticide poisoning [70]. In the present study, pesticides were responsible 
for many fatalities and were the chemicals most frequently used by patients from rural 
areas. This implies that pesticide poisoning should be given special attention and 
requires intervention measures from health care givers and responsible persons in the 
community.  
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Envenomation was the most common cause of poisoning of natural origin and 
snakebite was the dominating cause in this group. The snakes in northern Vietnam are 
numerous and some kinds are very poisonous. The magnitude of this problem has also 
been highlighted from other countries [69, 71, 72]. 
The clinical features included respiratory failure, and approximately 8% of the 
poisoned patients required intubation and mechanical ventilation. Similar findings have 
been reported from Turkey [73]. The rate of decontaminating interventions such as 
gastric lavage and administration of cathartics in the present study was higher than that 
recently reported [74] and recommended [75] from countries in Europe and the USA. 
However, the rate of antidote treatment was low, probably mainly on account of poor 
access in Vietnam to these often expensive pharmaceuticals. 
The mortality rate in the present study was low compared to reports from some other 
developing countries [3, 29, 69, 72]. Similar mortality rates of approximately 1% have 
been reported, however, from Turkey [76, 77] and Iran [78]. Countries with high 
mortality rates have often also reported a high frequency of intake of very toxic agents, 
such as aluminum phosphide in a study from India [29], and paraquat in a study from 
Thailand [3].  
5.2 POTENTIALLY HAZARDOUS ENVIRONMENTAL FACTORS FOR 
POISONING IN RURAL VIETNAM (PAPER IV) 
The major finding was that the availability and accessibility of pesticides constitute the 
main risk factor for poisoning among ordinary people in rural parts of Vietnam. This is 
partly explained by the fact that many kinds of highly toxic insecticides, herbicides, and 
rodenticides are widely spread and commonly used in Vietnam, and partly by the lack 
of effective control regulations and strategies to reduce this threat to public health. 
Acute poisoning by agricultural pesticides is a well established public health problem in 
developing countries, with an estimated 300,000 deaths annually worldwide [79]. 
Previous scientific reports have suggested that the widespread availability of pesticides 
in rural communities is a crucial risk factor  in a majority of all fatal self-poisonings 
[80, 81]. Easy accessibility of pesticides to adults and children is also a reality in many 
other developing countries such as Sri Lanka and China [82, 83]. This fact requires a 
prompt poisoning-prevention approach to reduce the availability of pesticides, 
especially those that are most toxic.  
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A second finding was that another important source of toxins in the rural area of 
Vietnam is its poisonous flora and fauna. The hazardous habit of ingesting and 
otherwise using unusual and unknown herbs reflects the fact that remedies and 
traditional medicine are popular in this area and that many Vietnamese people do not 
believe that herbs are toxic. The lack of necessary public information and control 
regulations makes the situation worse.  This is an important problem not only in many 
Asian countries but also in other parts of the world [82, 84]. The belief that ingestion of 
some poisonous animals is good for health has resulted in the fact that many 
households raise venomous snakes for economic reasons, and life-threatening 
envenomations are not uncommon in Vietnam [85].       
Another risk factor for poisoning recorded in this study was the availability and 
inadequate storage of hazardous household products. Such products were commonly 
within reach of children and were sometimes stored in beverage bottles, thereby 
constituting a risk for unintentional poisoning. This finding is consistent with previous 
reports from other regions [3, 86, 87]. 
Self-medication, through retail pharmacies without professional consultation, was 
commonly reported in this study. The problem of drug utilization and self-medication 
in Vietnam has been reported previously [88]. In a recently published hospital-based 
study on poisoning in Vietnam [89], pharmaceutical overdose was recorded as one of 
the most common types of acute poisoning.      
5.3 CLINICAL FEATURES OF 60 PATIENTS ENVENOMED BY B. 
MULTICINCTUS (PAPER II) 
This study involves the largest number of patients severely envenomed by B. 
multicinctus reported in the literature so far. A few case series and epidemiologic 
studies have previously been reported, however, from the Southeast Asian region [54, 
55], Taiwan [90], and the south of China [56]. The major findings in this study were the 
high proportion needing mechanical ventilation and the high rate of acute 
hyponatremia. The study population was, of course, highly selected, as all patients were 
admitted to an ICU, but 54 severe cases from the area surrounding Hanoi during a 4-
year period definitely implies a grave prognosis if untreated. 
In accordance with other case series, the bite by B. multicinctus was found to occur 
commonly in rural areas, where the habitats of snakes overlap with the human 
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environment [54, 90]. Thus, agricultural workers clearly predominated among the 
victims. As also noted for other krait species such as B. caeruleus and B. candidus [62, 
91], the attacks of B. multicinctus usually occur during the night-time [54, 55]. The 
most common locations of the attacks in our study, the patients’ homes and the rice 
field, are rather similar to those reported in other case series [55, 90]. 
In previously reported B. multicinctus envenoming, the first neurological symptoms 
developed within a few hours after the bite [54, 55], and in envenoming by other krait 
species, they appeared within 12 hours [62, 92]. In the present study the first symptoms 
developed within a wide time-range of 0.5 to 24 hours. This should be considered 
regarding the duration of observation required in these patients. 
The neuromuscular symptoms and signs recorded in this study were in conformity with 
those described in previous case series of envenoming by B. multicinctus [54, 55], as 
well as by some other kraits [91-93]. Ptosis and ophthalmoplegia were frequently 
observed and often led to dry eyes and conjunctivitis, or even corneitis in one case. 
These events are important to recognize and require particular nursing cautions. 
Mydriasis was also recorded in a clear majority of the patients. The dilatation of the 
pupils was often maximal and was extremely persistent in some cases (Fig. 3). The 
commonly documented palatal paralysis with inability to swallow was one of the 
reasons for respiratory failure in the early phase of the ICU course, but was also a cause 
of extubation failure in some cases in the late phase. This should be carefully 
considered, concomitantly with respiratory muscle palsy in the respiratory management 
of these cases. The most severely affected patients developed generalized muscle 
paralysis and became completely unresponsive. This situation, combined with apnea 
and dilated pupils, may easily be misdiagnosed as brain death. Electroencephalography 
and nerve conduction studies therefore may be indicated in situations of uncertainty. 
The envenomed patients in the study often experienced general myalgia (Table 4). 
Some patients still had pain and numbness several months after discharge, requiring 
analgesic therapy. This phenomenon resembles the case of peripheral sensory 
neuropathy after a krait bite reported from Sri Lanka [92]. 
Tachycardia and hypertension were noted in many patients. These findings have been 
reported previously after snakebite by B. multicinctus [54] and also by another krait 
species, namely B. candidus [94]. It has been suggested that these clinical features may 
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be due to a decreased parasympathetic tone and may be treated with beta adrenergic 
blockers [94].  
The important finding of a rapidly developing significant hyponatremia in nearly half 
of the present study population was surprising. This electrolyte disturbance has not 
been reported previously after envenoming by B. multicinctus. We do not know the 
exact mechanism of the disturbance, but the sodium content of the urine was found to 
be elevated in a majority of the cases. Hyponatremia has been reported also following 
bites by the American coral snake, B. flaviceps and some other snakes. The mechanism 
underlying the electrolyte disturbance after that snakebite was reported to be a 
natriuretic peptide in the venom [95-97]. We strongly recommend that serum 
electrolyte levels be followed up in every patient envenomed by B. multicinctus, and 
that sodium be replaced immediately if necessary. 
Fifty-two patients or 87% of the study population needed mechanical ventilation. This 
finding emphasizes the seriousness of snakebite from this particular species. The 
duration of the artificial ventilation in our study was longer than that in a study from 
India describing severe neuroparalytic pulmonary status after different snake 
envenomations [98]. The recorded hospital mortality rate of 7% in our study, despite 
ICU treatment, also underlines the danger of envenoming by B. multicinctus. 
5.4 EFFICACY OF A NOVEL ANTIVENOM IN PATIENTS ENVENOMED 
BY B. MULTICINCTUS (PAPER III) 
The major findings in this controlled clinical trial were the favourable clinical efficacy 
of the tested antivenom and the lack of severe adverse reactions to this treatment. The 
significant results of the study were achieved despite the fact that 93% of the patients in 
the interventional group received the antivenom therapy more than six hours after the 
snakebite.  
Although an improvement of most tested symptoms was demonstrated in the 
antivenom group in the present study, the relative number of patients requiring 
mechanical ventilation was not reduced. The considerable delay before ICU admission 
is the likely explanation. The reason why some patients had to stay endotracheally 
intubated also after they had been weaned from the ventilator (Table 3), was that a 
palatal paralysis with inability to swallow sometimes persisted longer than the paralysis 
of the respiratory muscles. 
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A high rate of hyponatremia was observed in the study population as was also reported 
in a previous study on snakebite by this particular species. 
The average dose of the antivenom used in the present study was similar to the dose 
regimen used in a study in China, and in accordance with the recommended doses of 
other antivenom products used against bites by this Bungarus species [56]. With the 
aim of protecting its stability, the antivenom was not diluted in large amounts of 
solution in our study, but nevertheless was infused slowly during a period of one hour. 
Since skin testing is today not only considered unnecessary but also misleading, and 
pretreatment with antihistamine, epinephrine or corticosteroids is controversial, neither 
a skin test nor any pretreatment was performed in the present study [99-102].    
The reported frequencies of adverse reactions after different types of antivenom 
therapies have varied considerably. Acute reactions in 23-56% of the patients and high 
frequencies of serum sickness (up to 75%) have been recorded, but in other studies the 
rates of these complications have been rather low or approximately 10% [58, 103-105]. 
The main explanation for this discrepancy is that the older immunoglobulin-based 
antivenoms had several side effects, whereas more recent, purer equine antivenoms, 
containing F(ab’)2 or Fab fragments, produce few side reactions [59]. In our study, no 
severe reactions were recorded and a single moderate reaction was observed in a patient 
who developed urticaria. This was probably due to the high quality of the F(ab’)2 
antivenom in combination with rational dosing and slow administration. The transiently 
increased level of transaminases observed in another patient may possibly have had 
another, unknown explanation.  
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6 CONCLUSIONS 
• The hospital-based retrospective study of poisoning emergencies in Hanoi (Paper 
I) showed that a vast majority of the poisoning episodes occurred at home. This is 
important knowledge for the poisoning prevention efforts in the country. 
Moreover, the fact that hypnotic pharmaceuticals, heroin and pesticides were 
among the most commonly involved toxic agents and that they entailed an 
increased risk of a fatal outcome, show that more strict regulation of these 
potential toxins is crucial. Finally, the frequently recorded severe toxic symptoms, 
including coma, respiratory failure, hypotension and seizures, indicate a need for 
more specialized clinical poisoning units with intensive care facilities in Vietnam.  
• The cross-sectional community-based study from a rural part of Vietnam (Paper 
IV) pointed out that the availability and accessibility of pesticides constitute the 
main risk factor for poisoning among ordinary people in Vietnam. A second 
important source of toxins in the rural area of Vietnam is its poisonous flora and 
fauna. Other common risk factors for poisoning were the availability and 
inadequate storage of hazardous household products and self-medication, through 
retail pharmacies without professional consultation. 
• The study of 60 consecutive ICU-treated patients envenomed by B. multicinctus 
(Paper II) demonstrated that bites by B. multicinctus commonly occur in rural areas 
and during night-time. The first symptoms developed within a wide time-range of 
0.5 to 24 hours. The dilatation of the pupils was often maximal and extremely 
persistent in some cases. A majority of the patients developed generalized muscle 
paralysis. Eighty-seven percent of the study population needed mechanical 
ventilation. The new finding of a high rate of significant hyponatremia makes 
frequent laboratory monitoring and sometimes prompt sodium replacement 
imperative, and the severe clinical features recorded indicate an urgent need for a 
specific antivenom. 
• The controlled clinical trial of a novel antivenom against B. multicinctus (Paper III) 
clearly demonstrated its favourable efficacy and acceptable safety. The prospective 
study also confirmed the new finding in paper II of a high risk for development of 
significant hyponatremia after snakebite by this particular species.  
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INTRODUCTION
Poisoning is a common cause of medical
emergencies and a threat to public health. In
the year 2000, poisoning was the ninth most
common cause of death in young adults
worldwide and there were more than three
million cases of poisoning, with a mortality rate
of approximately 8% (Peden et al, 2002). It
has been estimated that over 90% of such
fatalities occur in developing countries (Peden
et al, 2002).
Vietnam is a developing country with ap-
proximately 84 million inhabitants. Its popula-
tion is relatively young, 39% consisting of chil-
dren and adolescents, while 17% are elderly
(Vietnam National Health Report 2006). In gen-
eral Vietnam is an agricultural country and
farmers account for nearly 75% of the popu-
lation, creating a large market for biocides and
other toxic chemicals. As a result of the ready
availability of poisons and the lack of an ef-
fective control strategy, poisoning has become
a major health problem throughout the coun-
try. However, reliable data on poisoning pat-
terns in Vietnam are sparse and incomplete,
and to our knowledge no study on clinical toxi-
cological issues from this country has been
published previously in any international medi-
cal journal.
The first Poison Control Center in Viet-
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Abstract. Poisoning is a sparsely studied but major health problem in Vietnam. In this hospital-
based retrospective study, the medical records of all cases of poisoning admitted to the Poison
Control Center in Hanoi from 1999 to 2003 were carefully reviewed. A total of 1,836 poisoning
emergencies were recorded. The female:male ratio was approximately 1:1. The largest number
of poisoned patients was found in the age-group 15-24 years. A vast majority of the toxic expo-
sures (74.1%) occurred at the patients’ homes. Suicidal poisoning constituted about one third of
all cases. The most commonly involved toxic agents consisted of the heterogeneous group “food
poisoning” (35.1%), pharmaceuticals (33.8%), toxins from poisonous animals, mostly snake bites
(12.6%), and pesticides (9.1%). On admission, two thirds of the patients had mild symptoms
(Poisoning Severity Score, PSS grade 1), while more than a quarter displayed pronounced clini-
cal signs of poisoning (PSS grades 2-4). The most frequently used poisoning-specific treatments
were gastric lavage (30.2%) and administration of activated charcoal (35.4%) and cathartics
(34.2%). Intensive care measures, such as mechanical ventilation and dialysis, were applied less
frequently, in 6.5% and 1.7%, respectively. Specific antidotes were given in 5.2% of the cases.
The total number of fatalities was 21 (1.1%) and 10 patients were discharged with a neurological
sequela. Hypnotic pharmaceuticals (mainly barbiturates), heroin, and pesticides were involved in
a majority of the fatalities. These data provide an important basis for poisoning prevention efforts
in developing countries such as Vietnam.
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nam (PCC) was started at Bach Mai Hospital
in Hanoi in 1998. The PCC consists of four
units: a clinical department with 20 beds and
intensive care facilities, a toxicological labo-
ratory, a poison information unit, and an
antivenom research unit.
The aim of the present study was to in-
vestigate the poisoning patterns in northern
Vietnam and also the frequency and charac-
teristics of poisoning emergencies admitted
to the clinical department of the PCC in Hanoi
during its first five years, with special focus
on a comparison of the years 1999 and 2003.
MATERIALS AND METHODS
In this retrospective study, the medical
records of all patients admitted to the PCC
between the years 1999 and 2003 because
of poisoning were carefully reviewed.
Poisoning was defined as drug overdose,
food poisoning, or exposure to any environ-
mental toxic substance. A study protocol was
developed from the existing IPCS-Case/Inci-
dent/Request Format (http://www.who.int/
ipcs/poisons/Minform-Eng.XLS). The protocol
was subsequently refined and covered all per-
tinent data including demographics, type of
poisoning, clinical findings, treatment, and
outcome.
The patients either presented directly to
the PCC or were referred from other hospitals
in northern Vietnam. The severity of each case
of poisoning was defined upon admission,
using the 5-graded Poisoning Severity Score
(PSS) criteria of the IPCS (Persson et al, 1998).
The outcome for each patient was clas-
sified into one of three categories: 1. recov-
ery, 2. sequela (an impairment of functioning
corresponding to a performance category of
2-4 on the 5-graded Glasgow-Pittsburgh Out-
come Scale (Jannett  and Bond, 1975;
Cummins et al, 1991) on discharge from hos-
pital), or 3. death during hospitalization.
 The chi-square test was used for statis-
tical calculations, and differences were con-
sidered significant if the p-value was <0.05.
RESULTS
The annual total number of patients ad-
mitted to the clinical department of the PCC
increased during the five-year period 1999-
2003 (Fig 1). However, patients with other di-
agnoses than poisoning were also treated in
the department, especially during its first few
years, when the existence of the PCC was not
very well known either to the population or to
the medical community of Hanoi.
In 1999 the number of patients with poi-
soning admitted to the PCC was 313 (59.5%
of the total number of admissions) and in 2003
the corresponding number was 1,523 (91.3%
of the total number of admissions). In 1999,
Occupation
n n n %
Service occupation 57 474 531 28.9
Student 54 358 412 22.4
None 85 256 341 18.6
Agricultural worker 82 250 332 18.1
Industrial worker 24 160 184 10.0
Other or unknown 11  20  36   2.0
Table 1
Occupational distribution of the poisoned patients for the years 1999 and 2003.
1999, n=313 2003, n=1,523 Total, n=1,836
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females accounted for 54.3% of the poison-
ings, and in 2003 this figure was 48.5%. The
largest number of poisoned patients was
found in the age-group 15-24 years. The
youngest patient treated during these two
years was 23 months old and the oldest was
96 years old (Fig 2).
The occupational distribution of the ad-
mitted cases of poisoning is presented in Table
1. In the year 1999, unemployed persons and
agricultural workers were the most common
occupational groups among the poisoned
patients. Four years later, students and people
working in service occupations increased dra-
matically.
A finding that did not change during the
5-year period was that a vast majority of the
toxic exposures occurred at home (Table 2).
Concerning the types of toxic agents
causing the poisoning, the most common in
1999 were pharmaceuticals and pesticides.
In 2003 food poisoning predominated, fol-
lowed by pharmaceuticals, toxins from poison-
ous animals (mostly snake venom), and pesti-
cides (Table 3). The pesticides were a miscel-
laneous mixture of toxic chemicals, but con-
sisted mainly of insecticides such as organo-
phosphates, carbamates, organochlorines, or
pyrethroids, or rodenticides, such as sodium
Location of exposure
n n n %
Home 266 1,094 1,360 74.1
Public space   14   102   116   6.3
Restaurant     1     95     96   5.2
Workplace   13     43     56   3.1
Rented house     2     18     20   1.1
Transport facility     2     12     14   0.8
Medical facility     6       9     15   0.8
Other or unknown     9   150   159   8.7
Table 2
Location of toxic exposures during the years 1999 and 2003.
1999, n=313 2003, n=1,523 Total, n=1,836
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Fig 1–The total numbers of patients admitted to the
first Poison Control Center (PCC) in Vietnam
during the years 1999-2003.
Fig 2–Age distribution of the poisoned patients
treated in the PCC during 1999 and 2003.
EXPERIENCES OF THE FIRST PCC IN VIETNAM
Vol  39  No. 2  March  2008 313
Type of toxin
n n n %
Food/beverages   19 626 645 35.1
Pharmaceuticals 160 460 620 33.8
Poisonous animals (mostly snakes)   29 202 231 12.6
Pesticides (including rodenticides)   61 107 168   9.2
Drug abuse (heroin)   13   72   85   4.6
Household/leisure products     6   12   18   1.0
Industrial / commercial products     8     7   15   0.8
Environmental contamination     1     9   10   0.5
Plants     3     6     9   0.5
Other or unknown   13   22   35   1.9
Table 3
Types of toxic agents involved in the cases of poisoning.
1999, n=313 2003, n=1,523 Total, n=1,836
Table 4
Routes of exposure among the poisoned patients during the years 1999 and 2003.
Route of exposure
n n n %
Ingestion 269 1,190 1,459 79.5
Bite   28   133   161   8.8
Sting     0     64     64   3.5
Injection     8     53     61   3.3
Inhalation     5     29     34   1.9
Cutaneous     0       7       7   0.4
Other or unknown     3     47     50   2.7
1999, n=313 2003, n=1,523 Total, n=1,836
Circumstance of exposure
n n n %
Unintentional (accidental)   82 823 905 49.3
Intentional-suicide 178 393 571 31.1
Intentional-misuse, abuse, malicious   34 234 268 14.6
Unknown   19   73   92   5.0
Table 5
Intentional versus unintentional poisoning.
1999, n=313 2003, n=1,523 Total, n=1,836
monofluoroacetate, zinc phosphide or antico-
agulant agents.
The clearly predominating route of expo-
sure was ingestion. Bites and stings from poi-
sonous animals were also relatively common.
Injection of heroin and inhalation of toxic gases
were examples of less common routes of ex-
posure (Table 4).
Compared with accidental toxic expo-
sures, the number of deliberate poisonings
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Severity of poisoning (PSS)
n n n %
None (0)   58     77   135   7.4
Minor (1) 163 1,051 1,214 66.1
Moderate (2)   39   259   298 16.2
Severe (3)   53   135   188 10.2
Fatal (4)    0      1      1   0.1
Poisoning-induced symptoms
n n n %
Reduced level of consciousnessa 83 235 318 17.3
Respiratory failure 64   83 147   8.0
Hypotension (systolic BP <90 mm Hg) 33   96 129   7.0
Rhabdomyolysis 12 111 123   6.7
Seizures 15   73   88   4.8
Bradycardia (heart rate <50)   5   28   33   1.8
Ventricular arrhythmiab 13   19   32   1.7
Acute renal failure 10   18   28   1.5
Acute hepatic failure   3   16   19   1.0
Gastrointestinal hemorrhage   2   15   17   0.9
Table 6
Poisoning Severity Score (PSS) on admission to the PCC.
1999, n=313 2003, n=1,523 Total, n=1,836
Table 7
The distribution of specified poisoning-induced symptoms recorded at the PCC.
aGlasgow Coma Scale score <13
bIncluding 26 patients with frequent ventricular extrasystoles and 6 with ventricular tachycardia.
1999, n=313 2003, n=1,523 Total, n=1,836
was larger in 1999 and smaller in 2003. In to-
tal, these two types of the toxic exposure were
approximately equally common. Suicidal poi-
soning constituted approximately one third of
all cases of poisoning (Table 5).
A majority of the poisoned patients dis-
played mild symptoms (PSS grade 1) on ad-
mission to the PCC. However, more than a
quarter of the total number of poisoned patients
showed pronounced clinical signs of poison-
ing and some had life-threatening symptoms.
During the year 1999, the relative proportion of
patients with severe poisoning (PSS grades 3-
4) was higher than during 2003 (16.9% and
8.9%, respectively, p<0.001) (Table 6).
The occurrence of specified poisoning-in-
duced symptoms recorded during the hospital
stay is shown in Table 7. The most common
signs of serious poisoning were a reduced level
of consciousness, respiratory failure, hypoten-
sion, rhabdomyolysis, and seizures.
The poisoning-specific treatments most
commonly used during the study years were
decontamination measures, such as adminis-
tration of cathartics, activated charcoal, gas-
tric lavage and skin decontamination. Inten-
sive care measures, such as mechanical ven-
tilation and dialysis, were used less frequently.
Specific antidotes were given in approximately
5% of all cases (Table 8).
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Main outcome 1999, n=313 2003, n=1,523             Total, n=1,836
n n n %
Recovery 306 1,499 1,805 98.3
Sequela     1       9     10   0.5
Fatal     6     15     21   1.1
Table 9
Main outcomes among the cases of poisoning at the PCC.
Treatment 1999, n=313 2003, n=1,523             Total, n=1,836
n n n %
Induced emesis   12   71   83   4.5
Gastric lavage 191 364 555 30.2
Charcoal, single dosage 143 437 580 31.6
Charcoal, repeat dosages   46   25   71   3.9
Cathartic 195 433 628 34.2
Skin decontamination   23   66   89   4.8
Irrigation of eye     4   12  16   0.9
Endotracheal intubation   64   83 147   8.0
Mechanical ventilation   56   64 120   6.5
Antidote administration   16   80   96   5.2
Hemodialysis     8   23   31   1.7
Table 8
Use of therapeutic interventions in the poisoned patients at the PCC.
The mean stay in the PCC was 2.10 ±
0.99 days. Of the total of 1,836 poisoned pa-
tients, 1,322 (72.1%) were discharged within
24 hours. However, 140 patients (7.6%) re-
quired hospitalization for more than one week.
The longest treatment duration was 62 days.
The main outcomes among the poisoned
patients treated at the PCC during 1999 and
2003 is shown in Table 9. The hospital mor-
tality rate was higher in 1999 (1.9%) than in
2003 (1%), but the difference was not statisti-
cally significant. The fatalities mainly resulted
from poisoning by hypnotic pharmaceuticals
(phenobarbital in 5 cases), heroin overdose
and some very toxic pesticides (Table 10).
DISCUSSION
The annual number of admitted cases of
poisoning increased rapidly during the initial
years of the first PCC in Vietnam. Similar find-
ings were reported from Thailand during the
same period (Wananukul et al, 2007), and
probably reflect an increasing awareness of
the existence of the PCC among members of
the medical society and the population at
large. Another explanation may be an increas-
ing awareness of the need of specialized care
of these emergencies.
From studies in Turkey, the female-to-
male ratio of poisoning-related emergencies
was reported to be 3:1. A majority of the poi-
soned patients in that country were younger
than 25 years of age (Özköse and Ayoglu,
1999; Tüfekçi et al, 2004). Studies in Malay-
sia (Fathelrahman et al, 2005) and India (Singh
and Unnikrishnan, 2006) also showed approxi-
mately the same demographic characteristics
ˆ
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of poisoned patients. In the present study, the
female-to-male ratio was almost 1:1. The
higher rate of unintentional poisonings in this
study may explain the difference.
The present study found the most com-
mon location for toxic exposures was the
patient’s home. This finding may provide a
basis for intervention measures and steps to-
wards an improved poisoning prevention strat-
egy in Vietnam.
Among underlying toxic agents in this
study, the heterogeneous group “food poison-
ing” was found to be the most frequent. Phar-
maceuticals constituted the second most
common group, in conformity with the gen-
eral pattern of poisoning in the USA and Eu-
rope, as well as in developing countries
(Hanssens et al, 2001; Fathelrahman et al,
2005). In Vietnam, medications are readily
accessible as a consequence of a lack of regu-
lations, which is a great problem, especially
concerning suicidal patients and children. This
fact constitutes another important issue for the
health care system and the government in
Vietnam to consider in their attempts to pre-
vent poisoning.
   Pesticides have been identified as the
agents responsible for a majority of deaths
from poisoning in developing countries (Singh
and Unnikrishnan, 2006; Wananukul et al,
2007). A study in Zimbabwe showed that pes-
ticides accounted for the largest proportion
of deaths from poisoning at both district and
provincial hospitals, indicating that mortality
from pesticides is a problem both in urban and
rural areas (van der Hoek and Konradsen,
2006). In a study in Sri Lanka it was found
that easily available pesticides in rural areas,
economic problems and family conflicts were
the main underlying causes of intentional pes-
ticide poisoning (Eddleston et al, 2006). In the
present study, pesticides were responsible for
many fatalities and were the chemicals most
frequently used by patients from rural areas.
This implies that pesticide poisoning should
be given special attention and requires inter-
vention measures from health care givers and
responsible persons in the community.
Envenomation was the most common
cause of poisoning of natural origin in this
study and snakebite was the dominating
cause in this group. The snakes in northern
Vietnam are numerous and some kinds are
very poisonous. The magnitude of this prob-
lem has also been highlighted from other
countries (Batra et al, 2003; Tagwireyi et al,
2006; van der Hoek and Konradsen, 2006).
The clinical features recorded in this
study included respiratory failure, and approxi-
mately 7% of the poisoned patients required
Toxic agents Total number of Case fatality
1999 2003 fatalities/No. of cases rate (%)
Hypnotic pharmaceuticals 3 4   7/382 1.8
Heroin 5 5/85 5.9
Pesticides 1 3   4/168 2.4
Herbal medicines 2 2/29 6.9
Hydrochloric acid 1 1/15 6.7
Cyanide 1 1/15 6.7
Snake venom 1   1/163 0.6
Table 10
Toxic agents associated with the fatalities.
Number of fatalities
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intubation and mechanical ventilation. Similar
findings have been reported from Turkey
(Goksu et al, 2002). The rate of decontami-
nating interventions, such as gastric lavage
and administration of cathartics, in the present
study was higher than that recently reported
(Chyka and Winbery, 2006) and recommended
(AACT and EAPCCT, 2004) from countries in
Europe and the USA. However, the rate of
antidote treatment was low, probably due to
poor access in Vietnam of these often expen-
sive pharmaceuticals.
The mortality rate in the present study was
low compared to reports from some other de-
veloping countries (Singh and Unnikrishnan,
2006; Tagwireyi et al, 2006; van der Hoek and
Konradsen, 2006; Wananukul et al, 2007). Simi-
lar mortality rates of approximately 1% have
been reported, however in Turkey (Tüfekçi et
al, 2004; Mert and Bilgin, 2006) and Iran (Afshari
et al, 2004). Countries with high mortality rates
have often reported a high frequency of intake
of very toxic agents, such as aluminum phos-
phide in a study from India (Singh and
Unnikrishnan, 2006), and paraquat in a study
from Thailand (Wananukul et al, 2007).
In conclusion, despite the hospital-based
retrospective design of this study, we consider
that the data obtained provide important in-
formation on the pattern of poisonings in
northern Vietnam. The finding that a vast ma-
jority of the poisoning episodes occurred at
home is of importance for the poisoning pre-
vention efforts in the country. Moreover, the
fact that hypnotic pharmaceuticals, heroin and
pesticides were among the most commonly
involved toxic agents and that they entailed
an increased risk of a fatal outcome, show that
more strict regulation and control of these
potential toxins is crucial. Finally, the frequently
recorded severe toxic symptoms, including
coma, respiratory failure, hypotension and
seizures, indicate a need for more specialized
clinical poisoning units with intensive care fa-
cilities in Vietnam.
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A Controlled Clinical Trial of A Novel Antivenom in Patients
Envenomed by Bungarus multicinctus
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Abstract In northern Vietnam, a majority of severely
envenomed patients are bitten by Bungarus multicinctus.
Hitherto, these victims have received supportive care
only. The aims of this study were to assess the possible
efficacy and side effects of a new antivenom. This trial
(ClinicalTrials.gov Identifier: NCT00811239) was per-
formed during 2004–2006 at an ICU in Hanoi. For ethical
reasons, the study was not randomized. All patients who
fulfilled the inclusion criteria during 2004–2005 were
prospectively enrolled, carefully recorded, and treated with
optimal supportive therapy (control group). The patients
who entered the study 2006 were treated with antivenom in
addition to supportive care (antivenom group). The inclusion
criteria were: envenomation by B. multicinctus, presence of
systemic envenomation, and (during 2006) provision of
written informed consent. Predefined endpoints were number
of patients requiring mechanical ventilation, duration of
mechanical ventilation, length of ICU stay, duration of
muscle paralysis, and number of patients with ventilator-
associated pneumonia. Eighty-one patients were included,
54 during 2004–2005 and 27 during 2006. Baseline
characteristics were similar in the groups. The antivenom-
group patients had a shorter duration of muscle paralysis of
the limbs (p<0.001), of the diaphragm (p<0.001), and of
ptosis (p<0.001). The duration of mechanical ventilation and
length of ICU stay were shorter in the antivenom group
(p<0.001). The rate of ventilator-associated pneumonia was
lower in the antivenom group (p<0.02). However, the
relative number of patients requiring mechanical ventilation
was not reduced in the antivenom group. The rate of adverse
reactions to the antivenom was 7.4%. A favorable efficacy
and acceptable safety of this antivenom were demonstrated.
Keywords Antivenom . Snakebite . Bungarus
multicinctus . Vietnam
Introduction
Venomous snakebites constitute a serious health problem in
many Asian countries. It has been estimated that approx-
imately 25,000–35,000 people die each year from snakebite
in that part of the world [1]. In Vietnam, the burden of
snakebites on public health motivated Calmette to conduct
original studies at the Vaccine Institute in Saigon over a
hundred years ago and to develop the first snake antivenom
ever [2].
In northern Vietnam, a vast majority of the most severely
envenomed patients are bitten by Bungarus multicinctus
(many-banded krait, Chinese krait), which is the only krait
species giving rise to significant morbidity and mortality in
the area. Its venom contains toxins which can cause severe
neuromuscular blockade, but which do not give rise to
swelling or necrosis at the site of the bite [1]. Alpha-
bungarotoxin is a postsynaptically active toxin which binds
to the acetylcholine receptors preventing binding of
acetylcholine. The result is a non-depolarizing type of
neuromuscular blockade. Moreover, the venom also con-
tains β and γ-bungarotoxins which act presynaptically and
depress the release of acetylcholine from the nerve endings.
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The presence of the latter toxins explains why attempts at
treatment with cholinesterase inhibitors, such as neostig-
mine, have not been very effective [3, 4].
Supportive care is an important part of the management
of snakebites, but antivenom administration is the mainstay
therapy in the majority of medically significant cases of
envenoming. Such specific therapy may dramatically
reduce the consequences of the envenomation [5–7].
Although antivenoms against B. multicinctus are available
in China and Taiwan, clinical reports regarding their
efficacy have only rarely been published [3, 8, 9]. In some
series of cases, antivenom treatment has been tried after
snakebites by other Bungarus species, but with rather
conflicting clinical results [10, 11]. In Vietnam, no specific
antivenom against B. multicinctus has been available until
recently, when it was developed and produced for clinical
use. The aims of this study were to assess the effectiveness
of this newly produced antivenom and to investigate its
possible side effects.
Materials and Methods
This prospective controlled clinical trial was carried out
during a 3-year period (2004–2006) at the Toxicological
Intensive Care Unit (ICU) of Bach Mai Hospital in Hanoi.
For ethical reasons and because the antivenom was not
clinically available until 2006, the study was not random-
ized or blinded. All patients who fulfilled the inclusion
criteria during the first two years of the study were
prospectively enrolled, carefully monitored, and treated with
optimal supportive therapy in the ICU (control group). The
patients who entered the study during the third year were
treated with antivenom therapy in addition to supportive care
(antivenom group). The patients were enrolled on the basis of
the following criteria: (1) envenomation by B. multicinctus,
(2) presence of clinical signs of systemic envenomation
(neuromuscular signs), and (3) (during the year 2006)
provision of written informed consent (by close relative if
the patient was unable to do so). Clinical data including a
number of defined clinical and laboratory examinations were
recorded for each case in a predetermined standardized
protocol during the entire 3-year study period. The severity
of the symptoms on recruitment was defined on the basis of
the five-graded (0–4) Poisoning Severity Score (PSS) [12].
During the year 2006, the patients were informed about
the possible benefits and risks of the antivenom treatment
and were able to withdraw at any time during the trial for
any reason. Five to ten ampoules of antivenom, depending
on the severity of muscle paralysis, were diluted with
isotonic glucose solution to a total of 50 ml and then
infused intravenously by electric pump for a period of 1 h.
The patients were monitored continuously during and after
the infusion to assess the efficacy of the treatment and any
adverse reactions. Six to 8 h after the end of the infusion, a
second infusion was administered, under similar conditions,
if no clinical improvement or adverse reaction had been
noted. Clinical examinations, in accordance with the study
protocol, were performed at least twice daily up to
discharge. The patients were also followed up 1 month
later and readmitted if associated symptoms developed or
became worse.
Predefined outcome endpoints were number of patients
requiring mechanical ventilation, duration of mechanical
ventilation, length of stay in the ICU, duration of a defined
degree of muscle paralysis, and number of patients who
developed a ventilator-associated pneumonia. The study
was conducted in accordance with the WHO Good Clinical
Practice guidelines and the Declaration of Helsinki. The
study design and the form for the written consent were
approved by the Ethics Committee of Hanoi Medical
University. Statistical analyses were performed using an
independent-samples t test or the Mann–Whitney test for
continuous variables and the χ2 test or Fisher’s exact test
for categorical variables. Differences were considered
significant if the p value was <0.05.
Antivenom
Venom pools from more than 100 specimens of Bungarus
candidus and B. multicinctus of different sizes, ages, and
sexes were collected from Vietnam. After milking, venoms
were immediately lyophilized and then detoxified with
glutaraldehyde, filtered, and stored at 4°C in bottles.
Immunization of horses with increasing doses of the
antigen described above was performed once a month for
7 months. The immunoglobulin fraction from each of the
pooled horse plasma samples was pepsin-digested and then
salt-precipitated to produce F(ab′)2 fragments. The antivenom
was supplied in liquid form, 2,000 units per ampoule. The
antivenom was approved for the use under discussion in the
manuscript by the National Institute for Control of Medico
Biological Products, Ministry of Health in Vietnam, but it
has not yet become a commercial product.
Results
During the 3-year study period, a total of 81 patients
fulfilled the inclusion criteria and entered the study. Of
these, 54 patients were included during the years 2004 and
2005 (control group) and 27 during 2006 (antivenom group).
The baseline characteristics were similar in the two groups,
and are presented in Table 1. Most patients were male and
of a productive age. Children below the age of 15 years
J. Med. Toxicol.
represented 14% of the study population and elderly patients
(>60 years) accounted for 4%. Most of the patients developed
their first symptoms within approximately 3 h after the
snakebite, and were admitted to the ICU later than 6 h after
the bite. All included patients displayed moderate or severe
envenomation on admission according to the PSS criteria,
with similar severity in the two groups.
The time span between the snakebite and the start of
antivenom therapy was 19±9 h, ranging from 5 to 38 h.
Twenty patients were treated by antivenom within 24 h
after the bite (only two patients within 6 h). The average
dose of administered antivenom was 8.1±3.2 ampoules,
ranging from 5 to 17 ampoules.
The patients in the antivenom group had a significantly
shorter duration of paralysis of the extremities, the
diaphragm, and of ptosis. Hyponatremia was a common
finding in the study population. The proportion of patients
with marked hyponatremia (serum sodium level of less than
130 mmol/L) was somewhat lower in the antivenom group,
and severe hyponatremia (sodium level <120 mmol/L or
symptomatic) was only observed in the control group (two
patients). The rate of ventilator-associated pneumonia was
significantly lower in the antivenom group (Table 2).
Table 3 presents the treatment measures in the two
groups. There was no fatality. The relative numbers of
patients requiring endotracheal intubation and mechanical
ventilation were similar in the two groups. However, the
duration of mechanical ventilation and endotracheal intu-
bation and the length of the ICU stay were significantly
shorter in the antivenom group. No treatment with any
cholinesterase inhibitor was given during the 3-year study
period.
In the seven patients treated with antivenom later than 24 h
after the snakebite, the duration of mechanical ventilation and
the length of the ICU stay were longer than those in the 20
patients who received antivenomwithin 24 h (Mann–Whitney
test, p values 0.07 and 0.01, respectively).
No patient in the study developed severe acute anaphy-
laxis. The rate of adverse reactions was 7.4% (2/27). A
moderate allergic reaction in the form of urticaria was noted
in one patient. Liver transaminase levels were transiently
increased in another patient, in whom the maximum values
of aspartate transaminase (AST) and alanine transaminase
(ALT) were observed on the fifth day (344 and 442 U/L,
respectively, or approximately ten times the upper reference
levels). Serum sickness was not observed in the study.
Table 1 Baseline characteristics in the two study groups
Variables Control group Antivenom group Significance
Age (years) 34±15 36±17 NS
Sex NS
Male 38 (70%) 18 (67%)
Female 16 (30%) 9 (33%)
Time to development of first symptom (hours) 3.1±2.7 2.7±1.9 NS
Duration from snakebite to admission (number of patients) NS
Within 6 h 13 (24%) 9 (33%)
>6 h 41 (76%) 18 (67%)
Site of bite NS
Limb 49 (91%) 25 (93%)
Trunk 3 (6%) 1 (4%)
Unknown 2 (4%) 1 (4%)
Severity score on recruitment NS
Moderate (PSS 2) 9 (17%) 4 (15%)
Severe (PSS 3) 45 (83%) 23 (85%)
NS not significant; PSS poisoning severity score [12]
Table 2 A comparison between the two groups regarding some clinical findings during the stay in the intensive care unit
Clinical findings Control group Antivenom group Significance (p)
Duration of limb paralysis (days) 7.5±6.9 2.2±2.6 <0.001
Duration of diaphragm palsy (days) 7.0±7.0 1.6±1.6 <0.001
Duration of ptosis (days) 6.3±4.7 3.5±1.5 <0.001
Hyponatremia with serum Na <130 mmol/L (number of patients) 27 (50%) 9 (33%) 0.16
Ventilator-associated pneumonia (number of patients) 27 (50%) 6 (22%) 0.02
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Among the patients in the control group, none developed any
allergic reaction and none had significantly but transiently
elevated liver enzymes.
Discussion
The major findings in this clinical trial were the favorable
clinical efficacy of the tested antivenom and the lack of
severe adverse reactions to this treatment. The significant
results of the study were achieved despite the fact that 93%
of the patients in the interventional group received the
antivenom therapy more than 6 h after the snakebite.
Although an improvement of most tested symptoms was
demonstrated in the antivenom group in the present study,
the relative number of patients requiring mechanical
ventilation was not reduced. The considerable delay before
ICU admission is the likely explanation. The reason why
some patients had to stay endotracheally intubated also
after they had been weaned from the ventilator (Table 3)
was that a palatal paralysis with inability to swallow some-
times persisted longer than the paralysis of the respiratory
muscles.
A high rate of hyponatremia was observed in the study
population as was also reported in a previous study on
snakebite by this particular species [13].
The average dose of the antivenom used in the present
study was similar to the dose regimen used in a study in
China, and in accordance with the recommended doses
of other antivenom products used against bites by this
Bungarus species [9]. With the aim of protecting its
stability, the antivenom was not diluted in large amounts
of solution in our study, but nevertheless was infused
slowly during a period of 1 h. Since skin testing is today
not only considered unnecessary but also misleading, and
pretreatment with antihistamine, epinephrine, or corticoste-
roids is controversial, neither a skin test nor any pretreatment
was performed in the present study [14–17].
The reported frequencies of adverse reactions after
different types of antivenom therapies have varied consid-
erably. Acute reactions in 23–56% of the patients and
high frequencies of serum sickness (up to 75%) have
been recorded, but in other studies the rates of these
complications have been rather low or approximately
10% [5, 18–20]. The main explanation for this discrepancy
is that the older immunoglobulin-based antivenoms had
several side effects, whereas more recent, purer equine
antivenoms, containing F(ab′)2 or Fab fragments, produce
few side reactions [21]. In our study, no severe reactions
were recorded and a single moderate reaction was
observed in a patient who developed urticaria. This was
probably due to the high quality of the F(ab′)2 antivenom
in combination with rational dosing and slow administra-
tion. The transiently increased level of transaminases
observed in another patient may possibly have had another,
unknown explanation.
In view of the method of production of this new
antivenom, it seems reasonable to assume that it should
also be effective after bites by B. candidus (Malayan krait).
However, this remains to be shown in a clinical trial.
Limitations of the Study
Unfortunately, it was not possible to perform this study as a
randomized placebo-controlled trial. Therefore, we cannot
exclude that a certain degree of unintentional bias may have
influenced the recordings in the study protocol, even
though every effort to avoid this was undertaken.
Conclusion
In conclusion, the efficacy and safety of this new antivenom
were clearly demonstrated in this controlled clinical trial of
patients bitten by B. multicinctus.
Table 3 A comparison between the two groups regarding some treatment measures during the intensive care unit (ICU) stay
Outcome measures Control group Antivenom group Significance (p)
Duration of mechanical ventilation (days) <0.001
Mean (±SD) 8.6±8.1 2.3±2.5
Range 0–31 0–12
Duration of intubation (days) <0.001
Mean (±SD) 10.1±9.3 3.0±2.6
Range 0–40 0–12
Length of ICU stay (days) <0.001
Mean (±SD) 11.6±9.7 6.1±3.2
Range 1–46 1–15
Number of patients requiring mechanical ventilation 44 (81.5%) 23 (85.2%) NS
NS not significant
J. Med. Toxicol.
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